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The association between coping behaviours and cardiovascular 
disease and cancer in a Japanese population cohort 
日本人集団における対処行動パターンと心血管疾患及びがんとの関連に関する研究 
Abstract 
Background: Coping styles are used to deal with stress. This study aims to assess the 
association between coping styles, and cardiovascular disease (CVD) and cancer incidence 
and mortality in Japan. 
Methods: The Japan Public Health Center-based (JPHC) Study is a large population-based 
cohort. Participants were between 50-79 years of age and without a history of cardiovascular 
disease (for CVD end points) or cancer (for cancer end points), and provided complete 
answers on coping styles. CVD incidence and mortality analyses included 57,017 subjects. 
Cancer incidence and mortality analyses included 55,130 subjects. Cox regression models, 
adjusted for confounders, were used to determine Hazard Ratios (HR) and confidence 
intervals (CI).  
Results: Mean follow-up time was 7.9 - 8.0 years for CVD incidence and CVD mortality, and 
9.5 - 9.8 years for cancer incidence and cancer mortality, respectively.  
A fantasizing coping style was positively associated with incident CVD (HR=1.26, 95% CI: 
1.051.52) and stroke (HR=1.24, 95% CI: 1.011.53). Subanalyses on stroke subtypes 
indicated that fantasizing was positively associated with subarachnoid haemorrhage 
(HR=1.72, 95% CI: 1.012.94) and that planning was inversely associated with ischemic 
stroke (HR=0.82, 95% CI: 0.680.99). The inverse association between a planning coping 
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style and ischemic stroke remained significant even in sensitivity analyses which excluded 
cases in the first three years of follow-up. None of the coping styles were associated with any 
of the CVD mortality end points. 
None of the coping styles were associated with overall cancer incidence. Positive reappraisal 
was inversely associated with cancer mortality (HR=0.84, 95% CI: 0.720.97), a result 
which remained statistically significant even when excluding cases in the first three years of 
follow-up. A planning coping style was positively associated with cancers detected through 
screening (HR=1.27, 95% CI: 1.091.47). 
Conclusion: The results of this study indicate that in a Japanese population-based cohort, 
specific coping styles may be associated with cardiovascular disease incidence and cancer 
mortality as well as cancers detected through screening. These associations are most likely 
explained through the utilization of health promoting behaviours. 
Keywords: cardiovascular disease; cancer; cohort; coping; incidence; mortality; Japan. 
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1. INTRODUCTION 
1.1. Cardiovascular disease and cancer 
Cardiovascular disease (CVD) and cancer are the two major causes of death from 
noncommunicable diseases (NCD) in the world[1]. Over a ten-year period ranging from 2005 
to 2015, the global death toll due to CVD and cancer increased by 12.5% and 17.0% 
respectively[1]. Between 1990 and 2013, incident cases of all cancers except for Hodgkin 
lymphoma increased on a global level[2]. Moreover, CVD and cancer are among the leading 
causes of disease burden from NCDs, and disability adjusted life years have significantly 
increased for both diseases over a ten-year period (2005-2015)[3]. Projections estimate that 
CVD and cancer will be the cause of 23.3 million and 11.5 million deaths, respectively, in the 
world by the year 2030[4]. When comparing with the latest available data[1], the projected 
death toll over the next 13 years correspond to a 30% increase in cardiovascular deaths, and a 
31% increase in cancer deaths. 
CVD and cancer are also the two major NCDs in Japan, accounting for approximately 
two thirds of all deaths in the country[5] with stroke, ischemic heart disease (IHD) and cancer 
ranking in seven of the top ten causes of years of life lost in Japan[6]. Although a number of 
risk factors have been identified for both CVD and cancer, there is a need to identify 
additional risk factors to improve preventive efforts and to reduce the burden of CVD and 
cancer in Japan. 
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1.1.1. Stress and cardiovascular disease and cancer 
Stress is an independent risk factor for ischemic heart disease[7], and the association between 
stress and coronary heart disease cannot entirely be explained by its mediating effect on 
traditional risk factors[8]. Stress could be a risk factor of cardiovascular disease and mortality 
through both direct and indirect effects[9]. Direct effects may involve physiologic changes 
through the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system which 
could result in downstream cardiovascular effects such as increased blood pressure and 
increased heart-rate[10]. The indirect effects of stress exposure may instead affect behaviours 
such as smoking, or physical activity, which are related to health-risks[9, 10]. 
Both direct and indirect effects need to be considered also for the association between 
stress and cancer. One example of a possible direct connection between stress and cancer is 
proenkephalin, an endogenous opioid neurohormone precursor. Low levels of this 
neurohormone are strongly associated with a significantly increased risk of incident breast 
cancer in a large population and in an independent study population[11]. The lowest levels of 
this specific neurohormone occur in individuals with high levels of perceived stress, thereby 
indicating that stress may influence the prospect of cancer through a direct pathway.  
1.1.2. Personality traits and cardiovascular disease and cancer 
There are several population-based studies which have investigated the association between 
personality traits and CVD and cancer outcomes. An individual-participant meta-analysis 
found that high levels of conscientiousness are associated with reduced all-cause mortality 
rates[12], whereas another individual-participant meta-analysis focusing specifically on 
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cancer outcomes found no association between personality traits and cancer incidence or 
cancer mortality[13]. Conversely, when considering CVD mortality, a pooled analysis of 
three cohorts found that a conscientious personality is inversely associated with mortality 
from both coronary heart disease and stroke, whereas neuroticism and extraversion are 
associated with increased risk of coronary heart disease and stroke, respectively[14]. A 
Japanese study found that the personality traits conscientiousness, extraversion and openness 
may be inversely associated with all-cause mortality[15]. 
Given the relatively large number of available population-based studies which have 
investigated the association between personality traits and CVD and cancer outcomes, 
respectively, it may be of importance to investigate other relevant psychological measures, 
such as coping styles, and their association with specifically CVD and cancer outcomes. 
Contrary to the number of studies on personality traits, there are no available population-
based studies investigating the association between specific coping styles and incidence and 
mortality from CVD and cancer.  
1.2. Coping  
Coping styles are behaviours or strategies used to manage daily problems and psychological 
stress, a known important and modifiable risk factor for a range of health outcomes including 
cardiovascular disease and cancer[7, 10, 16-18]. The impact of stress can be minimized 
through adequate coping[19] or exacerbated through maladaptive coping[20, 21]. Coping is a 
process, and the term is defined by Lazarus as ‘[…] a person’s ongoing efforts in thought and 
action to manage specific demands appraised as taxing or overwhelming’[22]. As such, the 
14 
 
process approach to coping explains that an individual’s coping depends on the situation and 
is thus contextual. Given that situations may change over time, coping in turn may change to 
meet new demands and any dynamic stressful encounters that need to be dealt with[23, 24]. 
Conversely, the term coping styles denote coping which is considered to be a relatively stable 
characteristic over time[25]. A questionnaire which thus asks how individuals usually deal 
with problems, without specifying the nature of the problem, allows for an interindividual 
approach which represents a stable index of an individual’s coping style across different 
situations[25, 26]. Moreover, a specific research question investigating coping in relation to 
long-term outcomes may warrant coping style measures over coping as a process 
measure[25]. Indeed, in the current study, incident and mortality outcomes may occur years 
after coping has been assessed.  
Coping styles differ among individuals depending on their cognitive efforts and abilities 
and can be organised into strategies based on how the individual tackles a problem or 
stressor. Coping strategies are generally clustered into either approach and avoidance[27], 
problem-focused and emotion-focused[28], attention and avoidance[29], or a combination of 
them[26]. Whereas approach, problem-focused, and attention coping tends to focus on the 
stressor and deal with the source of stress, avoidance and emotion-focused coping is instead 
utilized to either avoid the stressor or to regulate the individual’s own emotions regarding the 
stressor. Hence, the potential impact of stress on an individual’s health could be directly 
related to the way stress is being dealt with, thereby allowing for coping styles that are 
favourable or detrimental with respect to health outcomes[30].  
Coping in itself cannot be assumed to be good or bad; one must take into account the 
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individual, the situation the individual is dealing with, the encounter outcome and whether or 
not the outcome is measured in the short or long run[23, 24, 29]. Avoidance strategies seem 
to work better in reducing stress in the short run whereas attention strategies seem to work 
more efficaciously over time[29]. Either strategy also works better than employing no 
strategy at all[29]. 
The categorization of coping strategies into specifically approach- or avoidance-oriented 
may be particularly important for health outcomes. There are benefits and disadvantages of 
the respective strategies[27], and they are associated with the processing of health threats[31]. 
In situations where the outcome can be affected or mitigated, the individual’s suitable and 
relevant actions are dependent on approach-oriented strategies oriented towards the 
stressor[27]. Such action may influence timing of treatment and necessary precautions to 
prevent exacerbation of illness. Conversely, the disadvantages of adopting avoidance coping 
on health outcomes that are amenable to change and which require action may be deleterious. 
Although avoidance-oriented strategies may be beneficial and alleviate any negative 
emotions and feelings of stress, they do this by orientating the individual away from the 
source of stress[27]. This may result in emotional numbness and a lack of awareness of the 
relationship between symptoms and trauma which may in turn impact treatment and 
recovery[27].  
The association between approach and avoidance coping strategies and the processing of 
health threats indicates that approach coping is associated with short time from symptom 
discovery to recognition of symptom seriousness and physician contact respectively[31]. 
Avoidance coping, on the other hand, is associated with long time from symptom discovery 
16 
 
to recognition of symptom seriousness[31]. 
Approach- and avoidance-oriented coping strategies are complementary as they can be 
used at different stages of the same taxing situation, e.g. avoidance may allow for emotional 
respite which provides the necessary energy to tackle the problems using approach-oriented 
responses[32]. This, in turn, may results in positive associations between the two coping 
strategies[31], and possibly allow for ‘ideal coping’ with stress where potential benefits are 
maximized and disadvantages are minimized[27]. 
 
1.2.1. Coping and cardiovascular disease 
There is growing evidence on the associations between stress and CVD. Psychological stress 
is considered an important risk factor for CVD[9, 10], and is associated with increased risk of 
stroke and coronary heart disease (CHD)[16]. Stress is a factor in both short-term and long-
term development of CVD through its direct involvement in physiologic response, indirect 
involvement with risk factors, as well as a prognostic factor among those with established 
disease[9]. Stress is however also a potentially modifiable risk factor[9, 10] which may be 
minimized or exacerbated through coping strategies[19-21], yet there is only limited 
knowledge available on the importance of coping strategies on CVD related outcomes. 
Certain coping behaviours or strategies may be associated with important CVD risk 
factors[33-36]. Coping strategies are associated with systemic inflammatory response[33]. 
Problem solving or positive reappraisal may be positively associated with body mass index 
(BMI) as well as overweight/obesity in men[34]. Coping styles are also associated with blood 
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pressure[35, 36], where an increased use of avoidant coping is associated with lower systolic 
blood pressure in men, but an increase in systolic blood pressure in women[35]. These 
variables are all possible mediators for the association between coping and CVD incidence 
and mortality, with the results indicating that coping styles may have a very important role to 
play in longitudinal studies on CVD outcomes. Yet, studies to date on the association between 
coping and CVD outcomes have been conducted in individuals already diagnosed with 
coronary heart disease. E.g. a case-control study[37] of individuals with chronic stable angina 
(CSA) (controls) and acute coronary syndrome (ACS) (cases) demonstrated that maladaptive 
and adaptive coping strategies may be positively and inversely associated respectively with 
ACS, while coping strategies at the time of a coronary event may be associated with disease 
severity at follow-up[38]. No studies have however investigated the association between 
coping styles and CVD incidence or mortality in a premorbid population. 
1.2.2. Coping and cancer 
Contrary to the paucity of available research on the association between coping and CVD, a 
number of studies have shown that specific stress coping strategies may be associated with 
cancer[39-45]. Women with cervical cancer are more likely to report passive stress-coping 
strategies than active or neutral coping strategies[39]. High scores on avoidant and passive 
coping styles assessed at the time of cancer diagnosis are associated with an unfavourable 
evolution of cancer as assessed by cancer stage, and related diagnostic tests[40]. Furthermore, 
survival of breast cancer patients is inversely associated with behavioural escape-avoidance 
coping[42] while negative adjustment to disease is positively associated with mortality risk 
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and relapse of breast cancer at both 5- and 10-year follow-up[43]. Emotion-focused coping 
strategies are also associated with breast cancer mortality, where expression of emotions is 
related to better survival whereas suppression of emotions is related to worse survival[44]. 
For lung cancer patients, depressive coping, e.g. self-pity and arguing with fate, is associated 
with shorter survival[45]. Such results are, however, ambiguous as there are also studies 
which have failed to find any associations between coping styles and course of cancer[46], or 
cancer survival[47-50]. The major limitations of the published research on the association 
between coping strategies and cancer are the small sample sizes and that studies have focused 
solely on individuals already diagnosed with an illness prior to the assessment of coping 
styles. When considering that coping is contextual[24, 28] and that coping strategies may 
change following diagnosis with severe illness such as cancer[51], the use of a healthy 
population is crucial for the recognition of any true association between premorbid coping 
styles and cancer outcomes. To our knowledge there are no such studies to date.  
Two main hypotheses have been suggested to explain the relationship between coping 
and the course of cancer[45]: a biological (direct) effect which considers the influence of 
coping on immune function, and a behavioural (indirect) effect which focuses on individuals’ 
own health conscious behaviours, e.g. attendance of screening examinations, and reactions to 
their illness including compliance with treatment and follow-up.  
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1.3. Objectives 
There is only limited evidence available on the association between coping styles and CVD 
and cancer outcomes. The main objectives of the present study are thus, by using a large 
general population cohort: 
 To assess the association between coping stylesboth approach-oriented and 
avoidance-oriented and CVD incidence and mortality, and 
 To identify the impact of premorbid coping styles on cancer incidence and mortality. 
 
The study aimed to clarify the prospective association of coping style and incidence and 
mortality of cardiovascular diseases and cancer using data from a community-based 
prospective study in Japan. A main hypothesis is that the coping styles of planning, consulting 
someone, and positive reappraisal will be associated with reduced incidence and mortality, 
whereas the coping styles of fantasizing, avoidance and self-blame will be associated with 
increased incidence and mortality of CVD and cancer outcomes, respectively. In addition, 
since a combination of a planning coping style with other coping styles was reported to have 
a greater impact than that for a single coping style, associations between combinations of a 
planning coping style with each of the other coping styles was tested.  
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2. METHODS 
2.1. Setting 
The Japan Public Health Center-based prospective Study (JPHC Study) is a large cohort with 
a baseline population of 140,420 registered Japanese inhabitants identified by the population 
registries maintained by the local municipalities in 11 public health center (PHC) areas. 
Following the initiation of the first JPHC cohort aged 40-59 in 1990; the second JPHC cohort 
aged 40-69 was started in 1993. The five PHC of Cohort I are located in Ninohe (Iwate 
prefecture), Yokote (Akita prefecture), Saku (Nagano prefecture), Ishikawa (Okinawa 
prefecture), and Katsushika-kita (Tokyo metropolis). The six PHC of Cohort II are located in 
Kashiwazaki (Niigata prefecture), Kasama (Ibaraki prefecture), Tosayamada (Kochi 
prefecture), Arikawa (Nagasaki prefecture), Miyako (Okinawa prefecture), and Suita (Osaka 
prefecture). Surveys of JPHC-study participants were conducted at baseline and at 5-year and 
10-year intervals. The study design has been described in detail elsewhere[52], and the study 
has been approved by the institutional review board of the National Cancer Center (approval 
number: 13-021) and the University of Tokyo (approval number: 10508), Japan.  
Starting point for the present study was the third survey (2000-2004) which included 
questions on coping styles and information on lifestyle factors. Participants were individuals 
who responded to the self-administered 10-year follow-up questionnaire at age 50-79 years. 
2.2. Study population 
The study population was defined as all registered Japanese inhabitants aged 40-59 in cohort 
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I and 40-69 in cohort II in 11 public health center (PHC) areas, identified by the population 
registries maintained by the local municipalities. Two PHC areas (Tokyo and Osaka) were 
excluded from the present analysis as complete data was unavailable for incidence of 
myocardial infarction (MI), and stroke. 
At baseline, there were 116,974 individuals identified in the study population after 
excluding subjects from Tokyo and Osaka (n=23,446) (Figure 1). Moreover, after excluding 
persons with non-Japanese nationality (n=51), duplicate enrolment (n=4), a late report of 
emigration occurring before the start of the baseline study (n=392), ineligibility due to an 
incorrect birth date (n=7), and persons who had died, moved refused follow-up or had been 
lost to follow-up before the starting point (n=3378), 113,142 individuals remained in our 
cohort. There were a total of 87,934 respondents to the third survey (response rate: 78%).  
For analyses of CVD end points we excluded individuals with a history of CVD before 
starting point (n=5,474), and those who failed to provide complete answers on coping 
(n=25,443), leaving a total of 57,017 individuals in the present study.  
For cancer analyses we excluded individuals who failed to provide complete answers on 
coping (n=27,554) and those with a history of cancer before starting point (n=3469). 
Additionally, to diminish the effects of reverse causality, a further 1781 individuals with a 
body mass index (BMI) less than 18.5 kg/m2 (a possible sign of occult disease) were 
excluded as we confirmed the same results before and after their exclusion. There were a total 
of 55,130 participants included in our analyses of cancer end points.
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Figure 1: Flowchart depicting the inclusion and exclusion of study participants for 
cardiovascular disease (CVD) and cancer analyses respectively
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2.3. Follow-up  
All participants for CVD end points were followed from starting point until 31 December 
2009. Participants for cancer end points were followed from starting point until 31 December 
2011. 
2.4. Assessment of cardiovascular disease outcomes 
2.4.1. Identification of cause of cardiovascular mortality 
Information on the cause of death for deceased participants was obtained, with the permission 
of the Ministry of Health, Labour and Welfare, from death certificates on which the cause of 
death is defined according to the International Statistical Classification of Diseases and 
Related Health Problems, tenth revision (ICD-10)[53]. Residency registration and death 
registration are required by the Basic Residential Register Law and Family Registry Law, 
respectively, and the registers are thought to be complete.  
The cardiovascular disease end points of the current study were mortality from IHD 
(ICD-10: I20-I25), cerebrovascular disease (ICD-10: I60-I69), as well as combined mortality 
from IHD and cerebrovascular disease (hereafter ‘CVD mortality’). 
 
2.4.2. Identification of cardiovascular disease incidence 
For cardiovascular disease incidence analyses, the endpoints in the current study were 
myocardial infarction (MI), stroke, and combined incidence of MI and stroke (hereafter 
‘CVD incidence’). The medical records were reviewed by hospital physicians, public health 
centre (PHC) physicians, or research physicians. MI was confirmed and diagnosed according 
to criteria of the MONICA project[54] whereas stroke was diagnosed by Computer 
Tomographic scan and/or Magnetic Resonance Imaging according to the National Survey of 
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Stroke criteria[55]. Subtypes of stroke were classified as haemorrhagic (intraparenchymal or 
subarachnoid) or ischemic. 
2.5. Assessment of cancer outcomes 
2.5.1. Identification of cause of cancer mortality 
Information on the cause of death for deceased participants was obtained from death 
certificates with the permission of the Ministry of Health, Labor and Welfare. Cause of death 
is defined according to the International Statistical Classification of Diseases and Related 
Health Problems, tenth revision (ICD-10)[53] and the end point of the current study was 
mortality from cancer (ICD-10: C00-C97).  
2.5.2. Identification of cancer incidence 
Cancer cases were identified through cancer registries and notification from local hospitals in 
the study areas. Cancer site and histology were coded using the International Classification of 
Diseases for Oncology, Third Edition (ICD-O-3)[56]. For individuals with multiple cancer 
diagnoses, only the first recorded event during follow-up was considered.  
Localized cancer was defined as cancer that at time of diagnosis had no distant 
metastases and had not spread to regional lymph nodes or adjacent organs. Screening-
detected cancers were defined as cancers detected through screening examination only. 
2.6. Assessment of exposure 
2.6.1. Coping styles 
The main variable of interest in the current study was coping. The Stress and Coping 
Inventory (SCI) uses 25 items to define one measure of coping: ‘Responses to stress’ which 
in turn consists of 25 items used to assess six responses to stress (three positive responses and 
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three negative responses)[57]. Using an adaptation of questions from the Japanese version of 
the Stress and Coping Inventory (SCI)[58], we evaluated six coping responses (planning, 
consulting someone, fantasizing, positive reappraisal, self-blame, and avoidance). The SCI 
has been validated for use among Japanese college students[58], but has not been validated 
for use in the JPHC Study population. However, the coping questions have previously been 
used as the main exposure in a prospective study on suicide in the JPHC Study[59]. 
Participants responded to one question: ‘How do you handle various problems and events 
that you experience daily?’ by providing the extent to which they used a specified approach, 
each of which represented a specific coping style: 1. Make a plan and carry it out (planning); 
2. Consult with someone (consulting); 3. Hope or fantasize about being able to change it 
(fantasizing); 4. Endeavor to find the positive side of the situation (positive reappraisal); 5. 
Blame and criticize yourself (self-blame); 6. Avoid those things and do something else 
(avoidance). Coping styles were dichotomized from a 5-step Likert-scale, and participants 
were considered to adopt a specific style if they reportedly used it “Fairly often” or 
“Extremely often” (in contrast to ‘Hardly ever’, ‘Infrequently’, or ‘Sometimes’).  
A network graph (Supplementary Figure 1) shows the correlation structure between the 
different coping styles for the 57,017 individuals included in the analyses for CVD endpoints. 
A correlation matrix for the different coping styles for the 55,130 individuals included in 
the analyses on cancer end points is available as a supplementary table (Supplementary Table 
1). 
2.7. Statistical analysis  
Statistical analyses were performed using SAS (SAS software version 9.3; SAS Institute Inc., 
Cary, NC) and the R statistical software (version 3.1.1; R Development Core Team, 2014). 
The significance level was set as p<0.05. 
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2.7.1. Covariates for statistical analyses 
The present study used age as a continues variable, with the definition of remaining 
covariates used in the statistical models as follows: gender (man or woman), alcohol 
consumption (none or occasional, <150, and ≥150 g ethanol/wk.), smoking (never, former 
smoker, <20 cig./day, >20cig./day), a self-reported history of diabetes (yes/no), total physical 
activity (leisure time and occupational activity measured in metabolic equivalent (MET) in 
kcal/kg/h (continuous variable)), body mass index (<18.5 kg/m2, 18.5-22.9 kg/m2, 23.0-24.9 
kg/m2, and ≥25 kg/m2), hypertension (systolic blood pressure ≥140 mmHg or diastolic blood 
pressure ≥90 mmHg), self-reported use of any prescribed medications by a physician 
(yes/no), unemployment (yes/no), having undergone screening examination (for men and 
women: blood pressure, blood test, electrocardiography, fundoscopy, chest radiograph, 
sputum cytology, gastric photofluorography, gastric endoscopy, faecal occult blood test, 
barium enema, or colonoscopy; for women: mammography or Papanicolau smear), and living 
arrangements (living alone (yes/no), living with a spouse (yes/no), living with children 
(yes/no), living with parents (yes/no), or living with other (yes/no)). Affirmative attendance at 
screening examination was defined as having attended at least one of the screenings listed. 
Hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg) 
was included as a covariate only in analyses on cardiovascular end points. In analyses on 
cancer end points, body mass index categories were defined as 18.5-22.9 kg/m2, 23.0-24.9 
kg/m2, and ≥25 kg/m2, and living arrangements were defined as living alone vs. living with 
spouse, child, parent or other (yes/no).  
2.7.2. Analysis of cardiovascular end points 
Person-years of follow up were calculated for each participant from starting point (10-year 
follow-up questionnaire) to the date of cardiovascular disease diagnosis (for incidence 
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analysis), the date of cardiovascular death (for mortality analysis), moving out of the study 
area or end of follow-up period (31 December, 2009), whichever occurred first. For  
individuals who withdrew from the study or were lost to follow-up, the date of censoring was 
set as the date of withdrawal or the last confirmed date of presence in the study. For 
individuals with multiple cardiovascular diagnoses, only the first recorded event during 
follow-up was considered. 
Hazard ratios (HR) and 95% confidence intervals (CI) were used to characterize the 
relative risk of incidence of MI, stroke or CVD, or cardiovascular mortality associated with 
coping styles. Cox proportional hazards models were used to estimate HR while controlling 
for potential confounders as described in the section above. All analyses were stratified on 
study area. Cancer screening examinations were included in our multivariable model on 
cardiovascular end points as they have the potential to independently serve as indicators of 
general health awareness and health conscious behaviour among participants. Interactions 
were considered between a) a planning coping style and the each of the five remaining coping 
styles, and b) between coping styles and the relevant demographic variables gender and age.  
Multivariable sensitivity analyses which excluded cases in the first three years of follow-
up were conducted for all end points to account for the possibility of reverse causation[60]. 
 
2.7.3. Analysis of cancer end points 
For each participant, person-years of follow up were calculated from the starting point (10-
year follow-up questionnaire) to the first date of cancer diagnosis (for incidence analysis), the 
date of cancer death (for mortality analysis), moving out of the study area or end of follow-up 
period, whichever occurred first. The date of censoring was set as the date of withdrawal or 
the last confirmed date of presence in the study for individuals who withdrew from the study 
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or were lost to follow-up respectively.  
The relative risks of cancer incidence and mortality associated with coping styles were 
characterized using HR and 95% CI. HR was estimated by Cox proportional hazards models 
while controlling for potential confounders. All cancer analyses were stratified on study area 
(9 PHC areas).  
Additionally, we conducted multivariable sensitivity analyses which excluded cases in 
the first three years of follow-up. 
Longitudinal sub analyses were conducted on the association between coping styles and 
1) cancer subtype (gastric, colon, rectal, liver, pancreatic, lung, breast, and prostate), 2) 
localized cancer at time of diagnosis, and 3) cancers detected through screening, respectively. 
Multivariable models for localized cancer incidence and screening-detected cancers were not 
adjusted for screening examination as this variable may lie on the causal pathway between 
coping and the respective end points.   
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3. RESULTS  
3.1. Cardiovascular disease 
3.1.1. Coping styles and baseline characteristics 
When comparing excluded (persons from Tokyo/Osaka and non-responders to questions on 
coping) with included individuals, excluded individuals were more likely to be older, women, 
hypertensive, unemployed, take medications, live alone, drink less, smoke less, and were less 
likely to have undergone a health screening examination (data not shown).  
The coping styles of positive reappraisal and planning were used by 21.8% and 19.9% of 
participants respectively, but only 3.9% of respondents actively utilized avoidance (Table 1). 
The majority of those who used planning (53.2%) were men whereas the highest proportion 
of women was seen for consulting someone (69.0%).  
Individuals who used a planning style had the lowest proportion of never smokers and 
none/occasional consumers of alcohol, as well as lowest proportion of individuals who were 
living alone. They also had the highest proportion of past and current smokers, overall 
consumers of alcohol, and those who lived with a spouse or a parent. Conversely, individuals 
who used an avoidance coping style had the highest proportion of those who had a BMI ≥ 25 
kg/m2, were unemployed, or lived alone. They also had the lowest proportion of those living 
with a spouse or parent, and attendance to a health screening examination. 
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Table 1: Characteristics at starting point for the total population and for subjects according to specific coping styles 
  Coping styles 
Variable 
Total 
population 
Planning 
Consulting 
someone 
Positive 
reappraisal 
Fantasizing Avoidance Self-blame 
  Yes No Yes No Yes No Yes No Yes No Yes No 
Number of subjects 57,017 11,355 45,662 4732 52,285 12,405 44,612 3915 53,102 2225 54,792 2642 54,375 
Proportion of  
total population (%) 
100 19.9 80.1 8.3 91.7 21.8 78.2 6.9 93.1 3.9 96.1 4.6 95.4 
Person years of follow-up 448,660 90,280 358,380 37,381 411,280 99,032 349,628 30,776 417,885 17,551 431,110 20,901 427,759 
Men (%) 47.3 53.3 45.7 31.1 48.7 46.1 47.6 36.7 48.0 40.5 47.5 38.2 47.7 
Age [mean (years ± s.d.)] 
60.3  
± 7.4 
60.0  
± 7.2 
60.4  
± 7.5 
59.8 
± 7.5 
60.3  
± 7.4 
59.8  
± 7.2 
60.4  
± 7.5 
59.4 
± 7.3 
60.4  
± 7.4 
60.6  
± 7.5 
60.3  
± 7.4 
59.3  
± 7.1 
60.3  
± 7.4 
Smoking status (%)              
 Never 63.3 60.0 64.1 74.0 62.3 64.2 63.0 69.0 62.9 66.4 63.2 69.6 63.0 
 Past 14.4 16.9 13.7 10.6 14.7 14.8 14.3 10.7 14.6 13.1 14.4 11.7 14.5 
 Current 22.4 23.1 22.2 15.5 23.0 21.1 22.7 20.3 22.5 20.6 22.4 18.7 22.5 
Alcohol consumption (%)              
 None/Occasional 62.4 57.7 63.6 70.9 61.6 61.5 62.6 65.4 62.2 65.1 62.3 66.0 62.2 
 <150 g. ethanol /wk. 12.7 14.4 12.2 12.5 12.7 13.7 12.4 13.0 12.6 12.0 12.7 12.0 12.7 
 ≥150 g. ethanol /wk. 25.0 28.0 24.2 16.6 25.7 24.8 25.0 21.6 25.2 22.9 25.0 22.0 25.1 
PA mean  
(MET-hours/day ± s.d.)] 
40.9  
± 7.2 
41.1  
± 7.1 
40.8  
± 7.2 
40.6  
± 6.9 
40.9 
± 7.2 
41.3  
± 7.0 
40.8  
± 7.2 
41.3  
± 7.3 
40.9  
± 7.2 
41.3  
± 7.5 
40.9  
± 7.2 
41.5  
± 7.5 
40.9  
± 7.2 
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Table 1 continued  Coping styles 
Variable 
Total 
Population 
Planning 
Consulting 
someone 
Positive 
reappraisal 
Fantasizing Avoidance Self-blame 
  Yes No Yes No Yes No Yes No Yes No Yes No 
BMI (%)              
 ≤ 18.5 kg/m2 3.4 3.2 3.4 3.9 3.3 3.0 3.5 4.6 3.3 3.9 3.4 4.4 3.3 
 18.5 – 23 kg/m2 39.9 39.8 40.0 41.0 39.8 39.3 40.1 40.1 39.9 39.4 40.0 41.3 39.9 
 23 – 25 kg/m2 25.8 26.7 25.5 25.2 25.8 26.7 25.5 23.7 25.9 24.0 25.8 23.6 25.9 
 ≥25 kg/m2 30.9 30.4 31.1 30.0 31.0 31.1 30.9 31.7 30.9 32.7 30.9 30.7 30.9 
Hypertension* (%) 35.8 33.7 36.3 32.7 36.1 32.8 36.7 34.6 35.9 36.4 35.7 35.6 35.8 
Unemployment (%) 13.6 12.5 13.9 12.1 13.8 11.2 14.3 12.5 13.7 15.2 13.6 12.8 13.7 
Screening  
Examination (%) 
86.8 89.1 86.2 90.4 86.5 88.8 86.2 87.3 86.8 85.2 86.9 87.4 86.8 
History of diabetes (%) 5.9 5.9 5.9 5.3 5.9 5.6 6.0 6.5 5.8 5.7 5.9 6.4 5.9 
Use of prescribed 
medications (%) 
40.6 40.1 40.7 44.4 40.2 38.6 41.1 41.9 40.5 40.1 40.6 44.0 40.4 
Living  
arrangements (%) 
             
 Living alone 6.1 6.0 6.1 6.5 6.1 6.1 6.1 6.7 6.1 7.9 6.0 7.0 6.1 
 Living with spouse 77.0 80.6 76.2 76.1 77.1 79.3 76.4 75.4 77.2 72.7 77.2 75.1 77.1 
 Living with children 53.2 52.4 53.4 55.9 52.9 53.0 53.2 55.2 53.0 53.6 53.2 51.9 53.2 
 Living with parents 15.6 16.1 15.5 15.9 15.6 15.7 15.6 15.7 15.6 13.5 15.7 15.3 15.7 
 Living with other 11.2 11.2 11.3 13.7 11.0 11.5 11.2 11.6 11.2 12.8 11.2 11.0 11.2 
*Hypertension defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90mmHg 
Abbreviations: BMI: Body Mass Index; MET: Metabolic Equivalent; PA: Total physical activity; s.d: Standard deviation.
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3.1.2. Incidence of MI and Stroke 
Mean follow-up time for incidence was 7.9 years. During follow-up, there were 304 MI and 
1565 strokes among the 57,017 subjects. The five-year cumulative probabilities of 
myocardial infarction and stroke occurrence were estimated at 0.34% and 1.64%, 
respectively. The coping style fantasizing was positively associated with incident CVD 
(HR=1.26, 95% CI: 1.051.52) and stroke (HR=1.24, 95% CI: 1.011.53) (Table 2 and 
Table 4). Exclusion of incident cases occurring in the first three years of follow-up attenuated 
the significant results, but directions of the association remained unchanged. There was no 
association between coping styles and incidence of MI (Table 3). 
Sub-analyses on incidence of stroke subtypes (Tables 5-7) indicated that fantasizing was 
positively associated with subarachnoid haemorrhage (HR=1.72, 95% CI: 1.012.94) and 
that a planning style was inversely associated with ischemic stroke (HR=0.82, 95% CI: 
0.680.99). Three-year sensitivity analyses attenuated the association between fantasizing 
and subarachnoid haemorrhage, whereas a planning style remained significantly inversely 
associated with ischemic stroke (HR=0.78, 95% CI: 0.620.98). 
There were no significant interactions between planning and any of the five other coping 
styles for any of the incident cardiovascular end points.
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Table 2: Cox proportional hazard models for the association between coping styles and 
incidence of cardiovascular disease (CVD) 
Variable 
 
CVD 
Coping styles 
Person 
Years 
Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 90,280 349 0.90  
(0.79-1.03) 
0.93  
(0.81-1.06) 
0.89  
(0.76-1.04) 
No 358,380 1519 Reference Reference Reference 
Consulting someone        
Yes 37,381 138 1.03  
(0.86-1.24) 
1.04  
(0.87-1.24) 
1.01  
(0.81-1.26) 
No 411,280 1730 Reference Reference Reference 
Positive reappraisal        
Yes 99,032 372 0.93  
(0.82-1.06) 
0.98  
(0.86-1.11) 
1.05  
(0.90-1.23) 
No 349,628 1496 Reference Reference Reference 
Fantasizing        
Yes 30,776 134 1.28**  
(1.06-1.55) 
1.26*  
(1.05-1.52) 
1.11  
(0.88-1.40) 
No 417,885 1734 Reference Reference Reference 
Avoidance        
Yes 17,551 69 0.94  
(0.73-1.20) 
0.92  
(0.72-1.17) 
1.05  
(0.79-1.39) 
No 431,110 1799 Reference Reference Reference 
Self-blame        
Yes 20,901 77 0.96  
(0.76-1.21) 
0.95  
(0.75-1.21) 
0.99  
(0.75-1.32) 
No 427,759 1791 Reference Reference Reference 
*p<0.05 
*Model 1 is adjusted for age and gender.  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass 
index, hypertension, living arrangements, and all coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; CVD: Cardiovascular disease; HR: Hazard Ratio.
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Table 3: Cox proportional hazard models for the association between coping styles and 
incidence of myocardial infarction (MI) 
 Variable 
 
MI 
Coping styles 
Person 
Years 
Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 90,280 65 0.97  
(0.71-1.32) 
0.99  
(0.72-1.35) 
0.89  
(0.60-1.31) 
No 358,380 239 Reference Reference Reference 
Consulting someone         
Yes 37,381 23 1.11  
(0.71-1.73) 
1.12  
(0.72-1.74) 
1.03  
(0.58-1.80) 
No 411,280 281 Reference Reference Reference 
Positive reappraisal          
Yes 99,032 68 1.03  
(0.76-1.41) 
1.09  
(0.79-1.49) 
1.10  
(0.75-1.61) 
No 349,628 236 Reference Reference Reference 
Fantasizing          
Yes 30,776 23 1.41  
(0.90-2.22) 
1.37 
(0.87-2.15) 
1.38  
(0.79-2.42) 
No 417,885 281 Reference Reference Reference 
Avoidance          
Yes 17,551 7 0.55  
(0.26-1.19) 
0.54  
(0.25-1.16) 
0.47  
(0.17-1.29) 
No 431,110 297 Reference Reference Reference 
Self-blame          
Yes 20,901 12 0.96  
(0.53-1.74) 
0.96  
(0.53-1.75) 
0.83  
(0.38-1.81) 
No 427,759 292 Reference Reference Reference 
*Model 1 is adjusted for age and gender.  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass 
index, hypertension, living arrangements, and all coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; HR: Hazard Ratio; MI: Myocardial infarction
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Table 4: Cox proportional hazard models for the association between coping styles and 
incidence of stroke 
Variable 
 
Stroke 
Coping styles 
Person 
Years 
Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 90,280 284 0.89  
(0.77-1.03) 
0.91  
(0.79-1.06) 
0.89  
(0.75-1.06) 
No 358,380 1281 Reference Reference Reference 
Consulting someone       
Yes 37,381 115 1.02  
(0.84-1.24) 
1.02  
(0.84-1.25) 
1.01  
(0.80-1.29) 
No 411,280 1450 Reference Reference Reference 
Positive reappraisal       
Yes 99,032 304 0.91  
(0.79-1.05) 
0.96  
(0.83-1.10) 
1.04  
(0.88-1.24) 
No 349,628 1261 Reference Reference Reference 
Fantasizing       
Yes 30,776 111 1.26*  
(1.02-1.55) 
1.24*  
(1.01-1.53) 
1.06  
(0.82-1.37) 
No 417,885 1454 Reference Reference Reference 
Avoidance       
Yes 17,551 62 1.01  
(0.78-1.31) 
0.99  
(0.76-1.29) 
1.16  
(0.86-1.56) 
No 431,110 1503 Reference Reference Reference 
Self-blame       
Yes 20,901 65 0.96  
(0.74-1.24) 
0.95  
(0.74-1.23) 
1.03  
(0.76-1.39) 
No 427,759 1500 Reference Reference Reference 
*p<0.05; 
*Model 1 is adjusted for age and gender.  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass 
index, hypertension, living arrangements, and all coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; HR: Hazard Ratio.
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Table 5: Cox proportional hazard models for the association between coping styles and 
incidence of intraparenchymal haemorrhage 
Variable 
 
Intraparenchymal haemorrhage 
Coping styles 
Person 
Years 
Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 90,280 95 1.11  
(0.86-1.44) 
1.17  
(0.90-1.51) 
1.16  
(0.85-1.60) 
No 358,380 354 Reference Reference Reference 
Consulting someone       
Yes 37,381 34 0.93  
(0.65-1.34) 
0.95  
(0.66-1.37) 
0.84  
(0.52-1.34) 
No 411,280 415 Reference Reference Reference 
Positive reappraisal       
Yes 99,032 93 0.87  
(0.67-1.13) 
0.88  
(0.67-1.15) 
0.90  
(0.65-1.25) 
No 349,628 356 Reference Reference Reference 
Fantasizing       
Yes 30,776 38 1.40  
(0.98-2.01) 
1.39  
(0.97-2.00) 
1.16  
(0.72-1.84) 
No 417,885 411 Reference Reference Reference 
Avoidance       
Yes 17,551 23 1.27  
(0.82-1.96) 
1.24  
(0.80-1.91) 
1.50  
(0.92-2.45) 
No 431,110 426 Reference Reference Reference 
Self-blame       
Yes 20,901 21 0.97  
(0.61-1.53) 
0.97  
(0.61-1.54) 
1.06  
(0.62-1.83) 
No 427,759 428 Reference Reference Reference 
*Model 1 is adjusted for age and gender;  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass 
index, hypertension, living arrangements, and all coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; HR: Hazard Ratio.
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Table 6: Cox proportional hazard models for the association between coping styles and 
incidence of subarachnoid haemorrhage 
Variable 
 
Subarachnoid haemorrhage 
Coping styles 
Person 
Years 
Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 90,280 27 0.83  
(0.52-1.31) 
0.86  
(0.54-1.37) 
0.95  
(0.53-1.70) 
No 358,380 133 Reference Reference Reference 
Consulting someone         
Yes 37,381 14 0.95  
(0.54-1.69) 
0.95  
(0.53-1.68) 
0.90  
(0.42-1.92) 
No 411,280 146 Reference Reference Reference 
Positive reappraisal         
Yes 99,032 33 0.92  
(0.59-1.42) 
0.95  
(0.61-1.48) 
1.25  
(0.72-2.16) 
No 349,628 127 Reference Reference Reference 
Fantasizing         
Yes 30,776 18 1.75* 
(1.03-2.99) 
1.72*  
(1.01-2.94) 
1.18  
(0.54-2.56) 
No 417,885 142 Reference Reference Reference 
Avoidance         
Yes 17,551 8 1.15  
(0.55-2.39) 
1.13  
(0.54-2.36) 
1.29  
(0.51-3.27) 
No 431,110 152 Reference Reference Reference 
Self-blame         
Yes 20,901 10 1.15  
(0.59-2.27) 
1.18  
(0.60-2.31) 
1.03  
(0.40-2.62) 
No 427,759 150 Reference Reference Reference 
*p<0.05; 
*Model 1 is adjusted for age and gender;  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass 
index, hypertension, living arrangements, and all coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; HR: Hazard Ratio.
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Table 7: Cox proportional hazard models for the association between coping styles and 
incidence of ischemic stroke 
Variable 
 
Ischemic stroke 
Coping styles 
Person 
Years 
Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 90,280 162 0.80* 
(0.67-0.97) 
0.82*  
(0.68-0.99) 
0.78*  
(0.62-0.98) 
No 358,380 794 Reference Reference Reference 
Consulting someone       
Yes 37,381 67 1.08  
(0.83-1.40) 
1.07  
(0.83-1.39) 
1.11  
(0.83-1.50) 
No 411,280 889 Reference Reference Reference 
Positive reappraisal       
Yes 99,032 178 0.93  
(0.78-1.12) 
1.00  
(0.83-1.20) 
1.08  
(0.87-1.35) 
No 349,628 778 Reference Reference Reference 
Fantasizing       
Yes 30,776 55 1.08  
(0.81-1.45) 
1.06  
(0.80-1.42) 
0.99  
(0.70-1.40) 
No 417,885 901 Reference Reference Reference 
Avoidance       
Yes 17,551 31 0.87  
(0.60-1.25) 
0.85  
(0.59-1.22) 
0.99  
(0.66-1.48) 
No 431,110 925 Reference Reference Reference 
Self-blame       
Yes 20,901 34 0.91  
(0.64-1.29) 
0.89  
(0.63-1.27) 
1.02  
(0.69-1.51) 
No 427,759 922 Reference Reference Reference 
*p<0.05; 
*Model 1 is adjusted for age and gender;  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass 
index, hypertension, living arrangements, and all coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; HR: Hazard Ratio.
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3.1.3. Mortality 
Mean follow-up time for mortality was 8.0 years. During this time, there were 191 and 331 
deaths from IHD and cerebrovascular disease respectively. The five-year cumulative 
probabilities of death from IHD and cerebrovascular disease were estimated, respectively, at 
0.20% and 0.33%. In the multivariable analyses (Tables 8-13), none of the coping styles were 
associated with any of the mortality end points.  
There were no significant interactions between planning and any of the five other coping 
styles for any of the mortality end points. 
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Table 8: Cox proportional hazard models for the association between coping styles and 
mortality from cardiovascular disease (CVD) 
Variable 
 
CVD 
Coping styles Person 
Years Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 91,505 86 0.85  
(0.70-1.10) 
0.91  
(0.70-1.18) 
1.02  
(0.76-1.37) 
No 363,376 436 Reference Reference Reference 
Consulting someone         
Yes 37,873 38 1.11  
(0.79-1.57) 
1.06  
(0.75-1.50) 
1.13  
(0.77-1.67) 
No 417,007 484 Reference Reference Reference 
Positive reappraisal         
Yes 100,310 85 0.75* 
 (0.58-0.98) 
0.82  
(0.63-1.07) 
0.83  
(0.61-1.12) 
No 354,570 437 Reference Reference Reference 
Fantasizing         
Yes 31,265 31 1.12  
(0.76-1.64) 
1.07  
(0.73-1.58) 
1.23  
(0.80-1.88) 
No 423,616 491 Reference Reference Reference 
Avoidance         
Yes 17,757 25 1.37  
(0.91-2.07) 
1.32  
(0.87-1.99) 
1.51  
(0.96-2.37) 
No 437,124 497 Reference Reference Reference 
Self-blame         
Yes 21,161 17 0.79  
(0.48-1.31) 
0.77  
(0.47-1.27) 
0.56  
(0.30-1.08) 
No 433,719 505 Reference Reference Reference 
*p<0.05; 
*Model 1 is adjusted for age and gender;  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass index, 
hypertension, living arrangements, and coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; CVD: Cardiovascular disease; HR: Hazard Ratio.
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Table 9: Cox proportional hazard models for the association between coping styles and 
mortality from ischemic heart disease (IHD) 
Variable 
 
IHD 
Coping styles Person 
Years Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 91,505 35 1.08  
(0.72-1.63) 
1.17  
(0.77-1.77) 
1.50  
(0.96-2.35) 
No 363,376 156 Reference Reference Reference 
Consulting someone       
Yes 37,873 9 0.73  
(0.37-1.45) 
0.72  
(0.36-1.43) 
0.81  
(0.38-1.69) 
No 417,007 182 Reference Reference Reference 
Positive reappraisal         
Yes 100,310 27 0.59*  
(0.38-0.94) 
0.66  
(0.41-1.04) 
0.64  
(0.39-1.08) 
No 354,570 164 Reference Reference Reference 
Fantasizing         
Yes 31,265 10 1.07  
(0.55-2.11) 
1.01  
(0.51-1.99) 
1.16  
(0.56-2.39) 
No 423,616 181 Reference Reference Reference 
Avoidance         
Yes 17,757 9 1.44  
(0.72-2.87) 
1.40  
(0.70-2.78) 
1.63  
(0.78-3.43) 
No 437,124 182 Reference Reference Reference 
Self-blame         
Yes 21,161 7 1.02  
(0.47-2.24) 
1.01  
(0.46-2.21) 
0.86  
(0.34-2.18) 
No 433,719 184 Reference Reference Reference 
*p<0.05; 
*Model 1 is adjusted for age and gender;  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass index, 
hypertension, living arrangements, and coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; HR: Hazard Ratio; IHD: Ischemic Heart Disease.
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Table 10: Cox proportional hazard models for the association between coping styles and 
mortality from cerebrovascular disease 
Variable 
 
Cerebrovascular disease 
Coping styles Person 
Years Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 91,505 51 0.74  
(0.53-1.03) 
0.79  
(0.56-1.10) 
0.79  
(0.54-1.17) 
No 363,376 280 Reference Reference Reference 
Consulting someone       
Yes 37,873 29 1.34  
(0.90-1.99) 
1.26  
(0.84-1.89) 
1.34  
(0.85-2.12) 
No 417,007 302 Reference Reference Reference 
Positive reappraisal       
Yes 100,310 58 0.85  
(0.62-1.17) 
0.92  
(0.67-1.28) 
0.95  
(0.65-1.39) 
No 354,570 273 Reference Reference Reference 
Fantasizing       
Yes 31,265 21 1.14  
(0.71-1.82) 
1.10  
(0.68-1.75) 
1.26  
(0.74-2.12) 
No 423,616 310 Reference Reference Reference 
Avoidance       
Yes 17,757 16 1.34  
(0.80-2.25) 
1.27  
(0.76-2.13) 
1.42  
(0.80-2.52) 
No 437,124 315 Reference Reference Reference 
Self-blame       
Yes 21,161 10 0.68  
(0.35-1.30) 
0.66  
(0.34-1.26) 
0.42  
(0.17-1.03) 
No 433,719 321 Reference Reference Reference 
*Model 1 is adjusted for age and gender;  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass index, 
hypertension, living arrangements, and coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; HR: Hazard Ratio.
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Table 11: Cox proportional hazard models for the association between coping styles and 
mortality from intracranial haemorrhage 
Variable 
 
Intracranial haemorrhage  
Coping styles Person 
Years Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 91,505 19 0.69  
(0.40-1.18) 
0.73  
(0.43-1.27) 
0.87  
(0.46-1.64) 
No 363,376 108 Reference Reference Reference 
Consulting someone       
Yes 37,873 9 1.13  
(0.56-2.28) 
1.09  
(0.54-2.20) 
0.85  
(0.33-2.16) 
No 417,007 118 Reference Reference Reference 
Positive reappraisal       
Yes 100,310 22 0.84  
(0.50-1.41) 
0.89  
(0.53-1.51) 
0.86  
(0.46-1.64) 
No 354,570 105 Reference Reference Reference 
Fantasizing       
Yes 31,265 9 1.36  
(0.66-2.80) 
1.28  
(0.62-2.64) 
1.71  
(0.75-3.87) 
No 423,616 118 Reference Reference Reference 
Avoidance       
Yes 17,757 7 1.59  
(0.73-3.48) 
1.52  
(0.69-3.33) 
1.31  
(0.47-3.65) 
No 437,124 120 Reference Reference Reference 
Self-blame       
Yes 21,161 4 0.68  
(0.24-1.92) 
0.65  
(0.23-1.83) 
0.22  
(0.03-1.66) 
No 433,719 123 Reference Reference Reference 
 *Model 1 is adjusted for age and gender;  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass 
index, hypertension, living arrangements, and coping styles. 
 ‡Model 3 excludes cases in the first three years of follow-up. 
 Abbreviations: CI: Confidence Interval; HR: Hazard Ratio.
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Table 12: Cox proportional hazard models for the association between coping styles and 
mortality from subarachnoid haemorrhage 
Variable 
 
Subarachnoid haemorrhage 
Coping styles Person 
Years Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 91,505 11 0.71  
(0.35-1.42) 
0.75  
(0.37-1.52) 
0.76  
(0.33-1.76) 
No 363,376 70 Reference Reference Reference 
Consulting someone       
Yes 37,873 7 1.25  
(0.56-2.78) 
1.11  
(0.47-2.64) 
1.71  
(0.70-4.15) 
No 417,007 74 Reference Reference Reference 
Positive reappraisal       
Yes 100,310 13 0.82  
(0.42-1.59) 
0.90  
(0.46-1.75) 
1.02  
(0.46-2.24) 
No 354,570 68 Reference Reference Reference 
Fantasizing       
Yes 31,265 3 0.56  
(0.17-1.85) 
0.54  
(0.16-1.80) 
0.51  
(0.12-2.22) 
No 423,616 78 Reference Reference Reference 
Avoidance       
Yes 17,757 4 1.45  
(0.52-4.06) 
1.32  
(0.47-3.70) 
2.12  
(0.74-6.05) 
No 437,124 77 Reference Reference Reference 
Self-blame       
Yes 21,161 3 0.89  
(0.27-2.93) 
0.89  
(0.27-2.92) 
0.39  
(0.05-2.91) 
No 433,719 78 Reference Reference Reference 
*Model 1 is adjusted for age and gender;  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass 
index, hypertension, living arrangements, and coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; HR: Hazard Ratio. 
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Table 13: Cox proportional hazard models for the association between coping styles and 
mortality from ischemic stroke 
Variable 
 
Ischemic stroke 
Coping styles Person 
Years Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning        
Yes 91,505 11 0.76  
(0.38-1.60) 
0.84  
(0.41-1.74) 
0.56  
(0.22-1.44) 
No 363,376 56 Reference Reference Reference 
Consulting someone       
Yes 37,873 9 1.91  
(0.91-4.02) 
1.80  
(0.85-3.80) 
1.88  
(0.81-4.41) 
No 417,007 58 Reference Reference Reference 
Positive reappraisal       
Yes 100,310 13 0.91  
(0.45-1.82) 
1.04  
(0.51-2.12) 
1.06  
(0.46-2.44) 
No 354,570 54 Reference Reference Reference 
Fantasizing       
Yes 31,265 6 1.63  
(0.66-4.02) 
1.53  
(0.62-3.77) 
1.76  
(0.64-4.80) 
No 423,616 61 Reference Reference Reference 
Avoidance       
Yes 17,757 3 1.09  
(0.33-3.56) 
0.99  
(0.30-3.25) 
1.31  
(0.39-4.38) 
No 437,124 64 Reference Reference Reference 
Self-blame       
Yes 21,161 1 0.28 
(0.04-2.11) 
0.28  
(0.04-2.08) 
0.37  
(0.05-2.82) 
No 433,719 66 Reference Reference Reference 
*Model 1 is adjusted for age and gender;  
†Model 2 is additionally adjusted for alcohol consumption, smoking status, history of diabetes, total 
physical activity, prescribed medication use, unemployment, screening examination, body mass 
index, hypertension, living arrangements, and coping styles. 
‡Model 3 excludes cases in the first three years of follow-up. 
Abbreviations: CI: Confidence Interval; HR: Hazard Ratio.
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3.1.4. Gender interactions 
Gender interacted significantly with a planning coping style only for the intracranial 
haemorrhage mortality end point (p for interaction: <0.05) (data not shown). In further 
gender-stratified analyses, a planning coping style was inversely associated with mortality 
from intracranial haemorrhage in men (HR=0.46, 95% CI: 0.230.92) but not among 
women.  
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3.2. Cancer 
3.2.1. Coping styles and baseline characteristics 
Table 14 shows baseline characteristics of the study population used for analyses on cancer 
end points. Individuals who used a planning coping style had the lowest proportion of never 
smokers and none/occasional consumers of alcohol, as well as the lowest proportion of 
individuals who were living alone or had a BMI ≥ 25 kg/m2. They also had the highest 
proportion of past- and current smokers, overall consumers of alcohol, and of those who had 
attended screening examinations. Conversely, individuals who used an avoidance coping 
style had the highest proportion of BMI ≥ 25 kg/m2, unemployed, and living alone. They also 
had the lowest proportion of attendees to a health screening examination.
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Table 14: Characteristics at starting point for the total population and for subjects according to specific coping styles 
  Coping styles 
Variable 
Total 
population 
Planning 
Consulting 
 someone 
Positive  
reappraisal 
Fantasizing Avoidance Self-blame 
  Yes No Yes No Yes No Yes No Yes No Yes No 
Number of subjects 55,130 10,954 44,176 4504 50,626 11,954 43,176 3729 51,401 2138 52,992 2534 52,596 
Proportion of  
total population (%) 
100 19.9 80.1 8.2 91.8 21.7 78.3 6.8 93.2 3.9 96.1 4.6 95.4 
Person years of follow-up 523,384 104,884 418,501 43,091 480,293 115,004 408,380 35,574 487,810 20,273 503,112 24,330 499,055 
Men (%) 48.5 54.7 46.9 32.1 49.9 47.2 48.8 37.7 49.2 41.6 48.7 40.1 48.9 
Age [mean (years ± s.d.)] 
60.3  
± 7.4 
59.9  
± 7.2 
60.4  
± 7.4 
60.0  
± 7.5 
60.3  
± 7.4 
59.7  
± 7.2 
60.5  
± 7.5 
59.3  
± 7.2 
60.4  
± 7.4 
60.6  
± 7.5 
60.3  
± 7.4 
59.4  
± 7.1 
60.4  
± 7.4 
Smoking status (%)              
 Never 62.7 59.3 63.6 73.6 61.8 63.7 62.5 68.5 62.3 65.7 62.6 68.6 62.4 
 Past 15.0 17.6 14.3 10.9 15.3 15.4 14.9 10.8 15.3 13.4 15.0 12.9 15.1 
 Current 22.3 23.1 22.1 15.6 22.9 21.0 22.7 20.7 22.4 20.8 22.4 18.5 22.5 
Alcohol consumption (%)              
 None/Occasional 62.1 57.2 63.3 70.7 61.3 61.2 62.4 65.2 61.9 64.8 62.0 65.3 62.0 
 <150 g. ethanol /wk. 12.7 14.4 12.3 12.4 12.8 13.8 12.4 12.8 12.7 11.8 12.8 12.4 12.7 
 ≥150 g. ethanol /wk. 25.2 28.4 24.4 16.9 25.9 25.0 25.2 22.0 25.4 23.4 25.2 22.3 25.3 
PA mean  
(MET-hours/day ± s.d.)] 
40.9  
± 7.2 
41.1  
± 7.0 
40.8  
± 7.3 
40.6  
± 6.9 
40.9  
± 7.2 
41.3  
± 7.1 
40.7  
± 7.2 
41.3  
± 7.3 
40.8  
± 7.2 
41.3  
± 7.4 
40.8  
± 7.2 
41.5  
± 7.6 
40.8  
± 7.2 
BMI (%)              
 18.5 – 23 kg/m2 40.7 40.4 40.8 41.9 40.6 39.7 41.0 41.8 40.7 40.8 40.7 42.2 40.7 
 23 – 25 kg/m2 26.8 27.7 26.6 26.1 26.9 27.7 26.6 24.8 27.0 25.1 26.9 24.8 26.9 
 ≥25 kg/m2 32.5 31.9 32.6 32.0 32.5 32.6 32.4 33.4 32.4 34.1 32.4 33.1 32.4 
 49 
 
Table 14 continued 
 Coping styles 
Variable 
Overall 
population 
Planning 
Consulting 
someone 
Positive  
reappraisal 
Fantasizing Avoidance Self-blame 
  Yes No Yes No Yes No Yes 
N
o 
Yes No Yes No 
Unemployment (%) 14.0 12.5 14.4 12.2 14.2 11.2 14.8 12.7 14.1 15.3 14.0 12.6 14.1 
Screening  
Examination* (%) 
87.0 89.3 86.4 90.7 86.6 88.9 86.4 87.5 86.9 85.5 87.0 88.0 86.9 
History of diabetes (%) 6.2 6.3 6.2 5.7 6.3 5.8 6.3 6.6 6.2 6.1 6.2 7.0 6.2 
Use of prescribed  
medications (%) 
42.1 41.5 42.2 45.5 41.7 40.0 42.6 43.5 41.9 41.7 42.1 46.3 41.8 
Living alone (%) 6.0 5.7 6.0 6.2 5.9 5.8 6.0 6.1 5.9 7.7 5.9 6.4 5.9 
*Screening Examination denotes either Blood pressure measurement, Blood test, Electrocardiography, Fundoscopy, Chest radiograph, Sputum cytology, 
Gastric photofluorography, Gastric endoscopy, Faecal occult blood test, Barium enema, Colonoscopy, Mammography, or the Papanicolau smear; 
Abbreviations: BMI: Body Mass Index; MET: Metabolic Equivalent; PA: Total physical activity; s.d. Standard deviation. 
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3.2.2. Cancer incidence 
Mean follow-up time for cancer incidence was 9.5 years. During follow-up time cancer was 
diagnosed in 5241 of our 55,130 participants. There was no association between coping styles 
and cancer incidence in the multivariable or sensitivity analyses (Table 15). 
There were no significant interactions between planning and any of the five other coping 
styles for overall cancer incidence. 
3.2.3. Cancer mortality 
Mean follow-up time for cancer mortality was 9.8 years, with 1632 cancer deaths occurring 
during follow-up. Positive reappraisal (HR=0.84, 95% CI: 0.720.97) was associated with a 
reduced risk of cancer mortality in the multivariable adjusted models (Table 16). The results 
remained statistically significant even when excluding individuals who died in the first three 
years of follow-up (HR=0.83, 95% CI: 0.710.98). 
There were no significant interactions between planning and any of the five other coping 
styles for overall cancer mortality. 
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Table 15: Cox proportional hazard models for the association between coping styles and 
cancer incidence 
Variable 
 
Cancer incidence 
Coping styles 
Person 
 Years 
Cases 
Model 1* Model 2† Model 3‡ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning    
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
Yes 104,884 1067 1.00  
(0.92-1.08) 
1.00  
(0.93-1.08) 
1.01  
(0.92-1.10) 
No 418,501 4174 Reference Reference Reference 
Consulting someone       
Yes 43,091 362 0.98  
(0.88-1.10) 
0.98  
(0.88-1.10) 
0.97  
(0.85-1.10) 
No 480,293 4879 Reference Reference Reference 
Positive reappraisal       
Yes 115,004 1083 0.97  
(0.90-1.04) 
0.98  
(0.91-1.06) 
0.99  
(0.91-1.09) 
No 408,380 4158 Reference Reference Reference 
Fantasizing       
Yes 35,574 311 1.03  
(0.91-1.16) 
1.01  
(0.90-1.14) 
0.93  
(0.80-1.07) 
No 487,810 4930 Reference Reference Reference 
Avoidance       
Yes 20,273 196 1.02  
(0.88-1.18) 
1.01  
(0.87-1.17) 
1.04  
(0.88-1.23) 
No 503,112 5045 Reference Reference Reference 
Self-blame       
Yes 24,330 204 0.93  
(0.81-1.08) 
0.94  
(0.81-1.08) 
0.93  
(0.79-1.10) 
No 499,055 5037 Reference Reference Reference 
*Model 1 is adjusted for age and gender;  
†Model 2 is adjusted for Model 1, alcohol consumption, smoking status, history of diabetes, total physical 
activity, prescribed medication use, unemployment, screening examination, body mass index, living 
arrangements, and coping styles 
‡Model 3 additionally excludes cases in the first three years of follow-up. 
Abbreviations: HR: Hazard Ratio; CI: Confidence Interval 
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Table 16: Cox proportional hazard models for the association between coping styles and 
cancer mortality 
Variable 
 
Cancer mortality 
Coping styles 
Person 
 Years Cases 
Model 1* Model 2† Model 3§ 
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
      
Planning    
HR  
(95% CI) 
HR  
(95% CI) 
HR  
(95% CI) 
Yes 108,635 299 0.94  
(0.82-1.09) 
0.97  
(0.84-1.11) 
1.01  
(0.87-1.18) 
No 431,887 1333 Reference Reference Reference 
Consulting someone       
Yes 44,373 103 0.98  
(0.80-1.21) 
1.00  
(0.81-1.23) 
1.00 
(0.79-1.25) 
No 496,149 1529 Reference Reference Reference 
Positive reappraisal       
Yes 118,890 283 0.81**  
(0.70-0.94) 
0.84* 
(0.72-0.97) 
0.83*  
(0.71-0.98) 
No 421,632 1349 Reference Reference Reference 
Fantasizing       
Yes 36,648 90 1.12  
(0.90-1.40) 
1.09  
(0.87-1.37) 
1.05  
(0.82-1.36) 
No 503,874 1542 Reference Reference Reference 
Avoidance       
Yes 20,957 49 0.86  
(0.64-1.15) 
0.83  
(0.62-1.11) 
0.85  
(0.61-1.16) 
No 519,565 1583 Reference Reference Reference 
Self-blame       
Yes 25,005 50 0.81  
(0.60-1.08) 
0.82  
(0.61-1.10) 
0.76  
(0.54-1.06) 
No 515,517 1582 Reference Reference Reference 
*p<0.05 
*Model 1 is adjusted for age and gender;  
†Model 2 is adjusted for Model 1, alcohol consumption, smoking status, history of diabetes, total physical 
activity, prescribed medication use, unemployment, screening examination, body mass index, living 
arrangements, and coping styles 
‡Model 3 additionally excludes cases in the first three years of follow-up. 
Abbreviations: HR: Hazard Ratio; CI: Confidence Interval 
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3.2.4. Cancer subtype 
In analyses on incidence of cancer subtypes (data not shown), a planning coping style 
significantly interacted with self-blame for incident colon cancer (p for interaction: <0.05); 
individuals who adopted a planning coping style as well as blamed themselves for a problem 
were at reduced risk of colon cancer (HR=0.27, 95% CI: 0.080.92). The planning coping 
style interacted with an avoidance style for incident lung cancer (p for interaction: <0.05), 
and those who utilized both a planning and avoidant coping styles were at increased risk of 
the disease (HR=2.52, 95% CI: 1.155.53). An avoidant coping style was also positively 
associated with an increased risk of breast cancer (HR=2.05, 95% CI: 1.353.11), with 
interactions also seen between planning and positive reappraisal and consulting someone, 
respectively, for breast cancer (p for interactions: <0.05). Whereas women who utilized a 
planning coping style as well as positive reappraisal were at a reduced risk of disease 
(HR=0.51, 95% CI: 0.280.92) those who utilized both a planning style and consulting 
someone were at an increased risk of disease (HR=2.61, 95% CI: 1.215.65).  
Following three-year sensitivity analyses, an avoidance coping style (HR=1.96, 95% CI: 
1.223.15) and the interaction between planning and positive reappraisal (HR=0.45, 95% 
CI: 0.230.87) remained significantly associated with the risk of incident breast cancer (p 
for interaction: <0.05). The interaction between planning and avoidance also remained 
statistically significant for incident lung cancer (HR=3.08, 95% CI: 1.237.70) (p for 
interaction: <0.05). 
For mortality end points, fantasizing was positively associated with gastric cancer 
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(HR=1.66, 95% CI: 1.002.76) and consulting someone was positively associated with 
mortality from rectal cancer (HR=2.47, 95% CI: 1.195.13). A planning coping style 
interacted with positive reappraisal for lung cancer mortality; individuals who reappraised 
things positively without utilizing a planning style were at reduced risk (HR=0.59, 95% CI: 
0.360.98) whereas those who utilized both planning and positive reappraisal were at an 
increased risk (HR=2.26, 95% CI: 1.114.63) of lung cancer mortality, respectively. 
Following exclusion of cases in the first three years of follow-up, only the respective 
associations between fantasizing and gastric cancer mortality (HR=1.91, 95% CI: 
1.133.24), and between consulting someone and rectal cancer mortality (HR=3.27, 95% 
CI: 1.556.91) remained significant.  
3.2.5. Localized cancer and screening-detected cancer 
Of the cancers registered in this study, 2563 cases were considered localized and 1782 were 
considered non-localized cancers at time of diagnosis. None of the coping styles were 
associated with cancer stage although there was a significant interaction between planning 
and self-blame (p for interaction: <0.01). Individuals who used both a planning coping style 
and blamed themselves were at a reduced risk of localized cancer (HR=0.57, 95% CI: 
0.380.86) (Table 17). No interactions were found between a planning coping style and the 
remaining five coping styles for non-localized cancers. 
A total of 1167 cancers were detected through screening, and 3148 of cancers were non-
screening-detected. Utilizing a planning coping style was associated with incidence of 
screening-detected cancers (HR=1.27, 95% CI: 1.091.47) (Table 18). No coping styles 
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were associated with non-screening-detected cancers. There were no interactions between 
planning and any of the other coping styles for either of the screening related cancer end 
points.
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Table 17: Cox proportional hazard models for the association between coping styles and localized/non-localized cancer incidence at time of 
diagnosis 
 
 
Incident Cancer 
Variable  Localized   Non-Localized 
Coping styles 
Person 
 Years Cases 
Model 1* Model 2†  
Cases 
Model 1* Model 2‡ 
HR  
(95% CI) 
HR  
(95% CI)  
HR  
(95% CI) 
HR  
(95% CI) 
         
Planning          
Yes 104,884 555 1.03  
(0.92-1.14) 
1.02  
(0.91-1.14)  
351 0.97  
(0.85-1.11) 
0.98  
(0.86-1.12) 
No 418,501 2008 Reference Reference  1431 Reference Reference 
Consulting someone          
Yes 43,091 188 1.12  
(0.96-1.31) 
1.11 
 (0.95-1.30)  
113 0.97  
(0.80-1.19) 
1.02  
(0.83-1.24) 
No 480,293 2375 Reference Reference  1669 Reference Reference 
Positive reappraisal          
Yes 115,004 569 1.08  
(0.97-1.21) 
1.08  
(0.97-1.21)  
354 0.97  
(0.85-1.12) 
0.97  
(0.85-1.11) 
No 408,380 1994 Reference Reference  1428 Reference Reference 
Fantasizing          
Yes 35,574 154 0.93  
(0.78-1.11) 
0.93 
 (0.78-1.11)  
104 1.03  
(0.83-1.28) 
1.02  
(0.82-1.27) 
No 487,810 2409 Reference Reference  1678 Reference Reference 
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**p<0.01; 
*Model 1 is adjusted for age and gender;  
†Model 2 is adjusted for Model 1, alcohol consumption, smoking status, history of diabetes, total physical activity, prescribed medication use, unemployment, 
screening examination, body mass index, living arrangements, coping styles and the interaction between planning and self-blame. 
‡Model 2 is adjusted for Model 1, alcohol consumption, smoking status, history of diabetes, total physical activity, prescribed medication use, unemployment, 
screening examination, body mass index, living arrangements, and coping styles. 
Abbreviations: HR: Hazard Ratio; CI: Confidence Interval 
Table 17 continued         
Avoidance          
Yes 20,273 103 1.05  
(0.86-1.29) 
1.04  
(0.85-1.28)  
63 0.94  
(0.72-1.22) 
0.94  
(0.72-1.22) 
No 503,111 2460 Reference Reference  1719 Reference Reference 
Self-blame          
Yes 24,330 110 1.19  
(0.93-1.52) 
1.19  
(0.93-1.52)  
61 0.80  
(0.61-1.05) 
0.79  
(0.60-1.04) 
No 499,055 2453 Reference Reference  1721 Reference Reference 
         
Planning*Self-blame 7736 38 0.57**  
(0.38-0.87) 
0.57**  
(0.38-0.86)  
- - - 
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Table 18: Cox proportional hazard models for the association between coping styles and screening-detected/not screening-detected cancers at 
time of diagnosis 
 
 
Incident Cancer 
Variable  Screening detected  Not screening-detected 
Coping styles 
Person 
 Years Cases 
Model 1* Model 2†  
Cases 
Model 1* Model 2† 
HR  
(95% CI) 
HR  
(95% CI)  
HR  
(95% CI) 
HR  
(95% CI) 
         
Planning          
Yes 104,884 297 1.27** 
 (1.09-1.48) 
1.27**  
(1.09-1.47)  
594 0.91  
(0.82-1.00) 
0.91  
(0.82-1.01) 
No 418,501 870 Reference Reference  2554 Reference Reference 
Consulting someone          
Yes 43,091 97 1.21  
(0.97-1.51) 
1.21  
(0.97-1.51)  
213 0.98  
(0.85-1.13) 
0.99  
(0.86-1.15) 
No 480,293 1070 Reference Reference  2935 Reference Reference 
Positive reappraisal          
Yes 115,004 272 1.01  
(0.86-1.18) 
1.01  
(0.86-1.18)  
621 1.03  
(0.93-1.14) 
1.03  
(0.93-1.14) 
No 408,380 895 Reference Reference  2527 Reference Reference 
Fantasizing          
Yes 35,574 78 1.16  
(0.90-1.49) 
1.16  
(0.91-1.50)  
170 0.95  
(0.81-1.13) 
0.96  
(0.81-1.13) 
No 487,810 1089 Reference Reference  2978 Reference Reference 
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**p<0.01 
*Model 1 is adjusted for age and gender;  
†Model 2 is adjusted for Model 1, alcohol consumption, smoking status, history of diabetes, total physical activity, prescribed medication use, unemployment, 
screening examination, body mass index, living arrangements, and coping styles. 
Abbreviations: HR: Hazard Ratio; CI: Confidence Interval 
Table 18 continued         
Avoidance          
Yes 20,273 51 1.10  
(0.82-1.48) 
1.08  
(0.80-1.45)  
116 0.94  
(0.78-1.15) 
0.96  
(0.79-1.16) 
No 503,111 1116 Reference Reference  3032 Reference Reference 
Self-blame          
Yes 24,330 47 0.84  
(0.61-1.15) 
0.84  
(0.61-1.16)  
112 0.91  
(0.74-1.11) 
0.91  
(0.74-1.12) 
No 499,055 2453 Reference Reference  1721 Reference Reference 
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4. DISCUSSION 
Coping styles, i.e. the way in which an individual deals with problems and stressors may be 
important for health outcomes. In particular approach- or avoidance-oriented coping 
strategies may be important for health-related endpoints, yet there are no studies which have 
investigated the association between coping styles and either cardiovascular disease (CVD) 
or cancer in a premorbid general population. Our study is thus the first of its kind to address 
the association of premorbid baseline coping styles with CVD and cancer outcomes using a 
general population cohort. The results for each end point will be discussed in accordance 
below. 
4.1. Coping and cardiovascular disease 
We have found that a fantasizing coping style is associated with a significantly increased risk 
of incident CVD, stroke and subarachnoid haemorrhage, whereas a planning coping style is 
associated with a reduced risk of incident ischemic stroke. Following sensitivity analyses 
which excluded incident cases in the first three years of follow-up, the associations between 
fantasizing and each of the three end points were attenuated although the directions of results 
remained unchanged. The exclusion of cases in the first three years of follow-up did not 
change the association between a planning coping style and the risk of incident ischemic 
stroke.  
Possible interrelations between covariates and their relation to cardiovascular events in 
premorbid individuals are presented in Supplementary Figure 2. Our findings of associations 
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between fantasizing and planning coping styles and incident cardiovascular events can, 
however, be explained without inferring any direct causality in particular when considering a 
number of important aspects. First, those who have been diagnosed with a disease must relate 
to additional behavioural variables influencing mortality, like attending follow-up visits, 
accepting advice from healthcare professionals, and complying with treatment. In fact, 
increased compliance with clinical appointments in newly diagnosed patients is significantly 
related to survival independent of severity of illness[61]. This may explain the lack of 
association between the individual coping styles with any of the mortality end points. Second, 
it may be important to take into account the contextual nature of coping[24, 28]. Although we 
have considered coping styles, which could be seen as relatively stable over time, it is 
possible that, in the wake of a traumatic experience such as stroke, MI or diagnosis of cancer, 
coping strategies or behaviours may change over time[51]. Such changes could potentially be 
beneficial and lead to post-traumatic growth and improved lifestyle habits[62]. Patients with 
active coping styles seem to have a healthier emotional adjustment to their illness[63], and a 
proactive coping style has been shown to correlate with patient information-seeking and 
medical decision-making[64]. Moreover, in a case-control study comparing admitted patients 
with chronic stable angina (CSA) to patients with acute coronary syndrome (ACS), 
individuals with ACS had significantly higher scores of maladaptive coping strategies than 
patients admitted with CSA, whereas the opposite was true for scores of adaptive coping 
strategies, i.e. they were significantly higher in those with CSA compared to patients with 
ACS[37].  
A study which considered coping as a state rather than a trait found that individuals who 
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adopted an approach-oriented coping strategy were at reduced risk of mortality from 
CVD[65]. It is therefore conceivable that a single measure of coping style may be insufficient 
as the exposure for CVD mortality end points, and that the approach-oriented coping styles 
used in the present study (i.e. planning, positive reappraisal and consulting someone) should 
instead be considered together rather than in isolation. An individual may at any given time 
use more than one approach-oriented style to solve taxing problems and the only currently 
available evidence in large premorbid populations with regards to CVD outcomes[65] indeed 
points in favour of such an approach to the specific measures of coping used in the present 
study. Individuals who adopt a premorbid approach-oriented strategy may easier achieve 
post-traumatic growth following diagnosis, or may change habits as a consequence of 
undiagnosed symptomatic disease, which in turn relates to minimized risk behaviour and 
reduced risk of death. This could possibly be explained by a person’s attitude toward medical 
care which has been suggested as a reason for decreased mortality among optimists[66].  
The use of a planning coping style was associated with reduced incidence of ischemic 
stroke. A reason why these associations were not found for MI or CVD-incidence could be 
that we have adjusted for several behaviours known to be associated with disease initiation, 
all of which can also be considered as indirect measures of coping. In accordance with 
previous studies where coping styles were found to be associated with blood pressure[35, 67] 
and BMI[34], two known risk factors and potential mediators of coping for cardiovascular 
events, the present study found that individuals using a planning coping style were less likely 
to be hypertensive, or have a BMI ≥ 25 kg/m2 than those who used an avoidant coping style. 
Previous research has highlighted the importance of coping mechanisms for blood pressure 
 63 
 
control through its influence on lifestyle factors[67]. Behaviours important for cardiovascular 
end points, e.g. smoking, alcohol consumption and physical activity have all been associated 
with both coping styles[19, 68, 69] and stress[70]. Although the multivariable models in this 
study adjusted for both hypertension and BMI, it may be more accurate to consider stratifying 
analyses according to these two important risk factors of cardiovascular disease given that 
they may be on the causal pathway between coping and CVD outcomes. Indeed, previous 
research has shown that the use of an avoidance coping strategy was associated with an 
increased risk of IHD mortality only among hypertensive individuals whereas 
overweight/obese individuals utilizing an approach coping strategy were at reduced risk of 
both CVD incidence and stroke[65]. 
An important covariate to consider for disease prevention is the attendance of screening 
examinations which is central for the detection of disease at an early phase. When adjusting 
for all the variables included in our analyses on cardiovascular disease, two of the three 
approach-oriented coping styles (i.e. planning and consulting someone) were significantly 
associated with attending screening examinations whereas an avoidant coping style was 
inversely associated with attending screening examinations (data not shown). This suggests 
that a coping style may play an important role for the participation in general health check-
ups. Thus, in a generally healthy population, coping styles, unlike stress which is known to 
both directly and indirectly affect CVD-risk[9], exert an indirect influence on CVD risk 
factors[34, 35]. 
Gender, age and cultural differences may all influence the association between coping 
styles and cardiovascular outcomes. Studies demonstrate gender differences in coping styles 
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where women utilize more avoidance coping than men[71]. Moreover, coping may play a 
different role in men and women’s cardiovascular functioning; increased use of avoidant 
coping is associated with lower systolic blood pressure in men, but an increase in systolic 
blood pressure in women[35]. Our significant interaction between gender and a planning 
coping style, and the inverse association observed between a planning coping style and 
mortality from intracranial haemorrhage in men but not in women thus further indicates that 
future studies on the association between coping and CVD end points should, when possible, 
consider gender-stratified analyses. Age may potentially also influence the impact of coping 
on health outcomes, although we found no significant interactions between age and coping in 
our study. However, compared to younger people, older individuals use problem-focused 
coping in perceived controllable situations[72]. They may therefore possibly adopt approach-
oriented coping on perceivably controllable health determinants, e.g. weight loss during 
overweight/obesity[65]. This is another reason in favour of analyses stratified according to 
risk factors[65]. Finally, there are ethnic differences in coping styles[73, 74] as individuals 
from Eastern Asian countries may adopt more avoidance coping as part of a collectivistic 
culture[75]. As such, avoidance must not be synonymous with maladaptive coping in Asian 
populations. Svensson et al.[65] showed that an avoidance coping strategy was associated 
with IHD mortality only among hypertensive individuals which indicates that avoidance 
coping among Japanese not necessarily equates to maladaptive coping unless coupled with a 
pre-existing CVD risk factor. Future studies conducted on different populations would allow 
for comparisons of potential intercultural differences in coping with stressors and the 
importance of these for cardiovascular outcomes. 
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4.2. Coping and cancer 
Our study is the only study to date to address the association of coping styles with cancer 
outcomes in a healthy general population. Previous studies have linked coping with 
survival[41-45] but were conducted in small populations and focused on coping styles in 
patients already diagnosed with cancer[39-50]. The current large population-based cohort 
study found that there was a significant association between the use of positive reappraisal 
and cancer mortality, and between a planning coping style and incidence of screening-
detected cancers. These results remained significant despite adjusting for a large number of 
possible confounders and excluding individuals with a history of cancer or possibility of 
occult disease (BMI<18.5). Moreover, the inverse association between positive reappraisal 
and cancer mortality remained significant despite excluding individuals who died in the first 
three years of follow-up. This minimizes the chance of reverse causation and indeed 
emphasizes the importance of premorbid coping styles on cancer mortality. 
Two explanations have been proposed for the association between coping styles and 
cancer mortality: biological (direct) and behavioural (indirect)[45]. Psychoneuroimmunology 
suggests that behaviour can influence immune response[76] with coping affecting the 
immune system[77-79] as well as the endocrine system[78]. Coping has been suggested to act 
as a possible moderator[77], or contributor[80] to stress-related immune changes[78, 81-83]. 
If a psychoneuroimmunological effect that could be translated into a clinical advantage exists, 
one would expect to see a reduced cancer incidence among individuals who use any of the 
approach-oriented coping styles (i.e. planning, positive reappraisal or consulting someone) 
given that positive coping reduces concentration of interleukin-4[79], a cytokine suggested to 
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promote tumour development[84]. We did not obtain these results probably because 
immunological changes resulting from approach-oriented coping strategies may be too small 
to modify the prospect of disease development. Conversely, the strong association between an 
endogenous opioid neurohormone precursor and incident breast cancer risk[11] suggests that 
biological effects of psychological stress may be of greater importance for cancer 
development than the biological effects resulting from specific coping styles. However, the 
biological effect of a reduced number of CD4+ cells associated with negative coping[79] 
could be masked by avoidance copers’ reluctance to acknowledge disease symptoms and 
avoiding medical consultations. Such avoidant coping would lead to undiagnosed cancers and 
reduced cancer incidence even in the presence of a biological effect. Indeed, a recent study 
has confirmed that there is a significant inverse association between the avoidance coping 
strategy and cancer incidence when excluding cases in the first three years of follow-up[85]. 
The associations between a planning coping style and screening-detected cancers may 
help to explain the found inverse association positive reappraisal and cancer mortality. In a 
recent study, both of these measures were considered in the definition of an approach oriented 
coping strategy, a measure which in turn was inversely associated with both cancer mortality 
and localized as well as screening detected cancers[85]. The results of that study promote the 
behavioural pathway hypothesis which involves early detection, patient information-seeking 
and medical decision-making[64] among those utilizing approach-oriented coping. It also 
indicates that it may be insufficient or inadequate to consider planning and positive 
reappraisal as isolated measures of coping. Results obtained in previous studies on the 
association between coping styles, cancer outcome and survival among cancer patients[39-
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45] could further be explained by emotional adjustment to existing illness[63], compliance 
with clinical appointments[61] and minimized risk behaviour with improved lifestyle habits 
following cancer diagnosis[62]. The additional finding of an inverse association between the 
combination of planning and self-blame with localized cancer incidence was unexpected, and 
any attempt to explain the results is highly speculative.  
Furthermore, our results may indicate the importance of not only considering 
localization/screening but also to take into account cancer subtype. A number of interactions 
between coping styles were seen depending on cancer site; those who utilized both planning 
and self-blame were at a significantly reduced risk of incident colon cancer. As suggested by 
Cardenal et al.[40], a self-blaming coping style might indicate that the individual focuses on 
his/her own responsibility for the origin of the problem. Self-blame may thus, in combination 
with a planning coping style reduce the risk of incident colon cancer. Individuals who utilized 
both a planning coping style and avoidance were at an increased risk of incident lung cancer. 
The combination of planning and avoidance has the potential to be both beneficial and 
detrimental depending on whether or not either of its components is used appropriately. It is 
therefore not only a question of knowing how to plan, but also a question of when it is 
appropriate in relation to the problem that needs to be addressed. Indeed, when used 
appropriately, avoidance coping may not necessarily be detrimental with regards to health 
outcomes, but instead offer emotional respite which provides the necessary energy to tackle 
the problems using approach-oriented responses[32]. However, if used inappropriately 
avoidance may instead orientate the individual away from the source of stress and result in 
emotional numbness and a lack of awareness of the relationship between symptoms and 
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trauma which may in turn impact treatment and recovery[27]. Indeed, there was a positive 
association between an avoidant coping style and breast cancer incidence. This is in 
accordance with previous findings indicating an association between difficult life events and 
breast cancer development[18], and maladaptive coping styles with breast cancer 
outcome[42, 43]. Our study also found that, with breast cancer incidence as the outcome, 
there were interactions between the approach-oriented coping styles; a planning coping style 
interacted beneficially with positive reappraisal and detrimentally with consulting someone, 
respectively. Women who used a combination of planning and positive reappraisal were at 
significantly reduced risk of breast cancer whereas those who used planning and consulting 
someone were at a significantly increased risk. As discussed in the section on coping styles 
and CVD above and as shown in the research on coping strategies and cancer outcomes[85], 
it may be important to consider the three approach-oriented coping styles in combination 
rather than in isolation. The results of our interactions between coping styles and incidence 
outcomes of specific cancer subtypes highlight the need for additional research on the topic. 
There was a positive association between fantasizing and mortality from gastric cancer. 
When considering that fantasizing could be a measure representative of avoidance, this 
finding may be due to the association between avoidance coping and the delay in processing 
health threats[31], and the disadvantages of using avoidance coping on health outcomes 
which require action[27]. The found positive associations between a consulting style and 
mortality from rectal cancer, as well as the results showing that positive reappraisal alone was 
inversely associated with lung cancer mortality, but a combination of positive reappraisal and 
planning was positively associated with lung cancer mortality requires additional studies in 
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order to understand their implication.  
4.3. Limitations 
There are several limitations in the present study. First, we must consider possible random 
misclassification; although coping style is a stable measure it was estimated at only one point. 
In addition, participants have been assigned to specific dichotomous coping styles which may 
lead to reduced variance and result in skewed or kurtotic scales with limited predictive 
ability[25]. We may also have underestimated the effect of avoidance coping on incidence 
and mortality outcomes if individuals who utilize an avoidance coping style are 
overrepresented among those who were excluded due to non-response on coping 
questions[86]. Comparisons between excluded and included individuals for CVD end points 
indicate significant differences between excluded and included participants on important 
characteristics for CVD. The number of participants who did not respond to all questions on 
coping and who were excluded from analyses may therefore be considered missing not at 
random and subsequently limit generalizability. However, the exclusion of non-responders 
was done intentionally owing to the association between non-response to psychosocial 
questions and risk of mortality from post-acute myocardial infarction[87]. Future studies 
could improve response rates through supplementary interviews. Additionally, although the 
coping questions used in the present studies are validated, they have not been validated 
specifically for the JPHC Study population which may have led to distorted results. Second, 
the associations found between coping and cardiovascular disease incidence and mortality 
and cancer mortality were marginal and we cannot exclude the possibility that they are the 
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result of chance finding. However, the direction of the associations in analyses which 
excluded events in the first three years of follow-up warrant further investigation in studies 
which can offer even longer follow-up times. Third, we have been unable to adjust for 
education or socioeconomic level, two important variables which can influence the coping 
repertoire. When including information on education available only for participants from 
cohort I of this study, associations between coping strategies and our end points were not 
substantially changed, but they were attenuated due to loss of statistical power owing to a low 
number of cases. Participants of Cohort I of the JPHC Study are less educated than national 
samples[88], however this group constitutes only half of the participants of our study and 
their educational level is not as great of a limitation as the absence of educational information 
for our entire population. Fourth, we have been unable to adjust for treatment-related factors 
(for mortality analyses) and immune parameters which are important when considering the 
direct and indirect mechanisms that may explain the effects of coping on cancer outcomes. 
Future studies should therefore consider using hierarchical models to determine structural 
relations between coping styles and treatment-related factors as well as behaviours related to 
cardiovascular risk such as smoking, drinking, and physical activity. Fifth, we have excluded 
individuals from Tokyo and Osaka and extrapolation of results to urban areas should be 
considered with caution. Crude stroke incidence density in the present study is however 
comparable to other Japanese cohorts such as the Circulatory Risk in Communities Study 
(CIRCS)[89]. Sixth, there is a possibility that genes may influence and act as confounders on 
coping styles. It is therefore a limitation that no genetic information was available for the 
participants of this study. Finally, results may be specific to the Japanese population and may 
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not be generalizable to other countries or ethnicities.  
4.4. Strengths 
Despite such limitations, this study is the first study on the association between premorbid 
coping styles and CVD and cancer incidence and mortality with a number of strengths. We 
have focused on baseline coping in healthy individuals while adjusting for a large number of 
confounders associated with incidence and mortality from ischemic heart disease, stroke and 
cancer. Furthermore, the findings presented are generalizable to the Japanese general 
population as the JPCH Study is the largest study in Japan to collect incident CVD data and 
has a large number of endpoints. The size of the JPHC Study, and the large number of 
participants have allowed us to present stratified results which could set the direction for 
future research on the association between coping and disease incidence and mortality. The 
JPHC Study also uses a validated coping questionnaire. Considering the simplicity and 
brevity of the coping questionnaire (six questions only), it may be possible to utilize the 
questionnaire in various settings to identify individuals who may be at reduced or increased 
risk of adverse health outcomes. 
5. Conclusion 
In a healthy general population, a fantasizing coping style is significantly associated with 
increased incidence of CVD, overall stroke, and subarachnoid haemorrhage whereas a 
planning coping style is associated with reduced incidence of ischemic stroke. Following 
sensitivity analyses excluding the first three years of follow-up, results were attenuated for 
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the association between fantasizing and the three end points, but not for the reduced risk 
associated with a planning style and ischemic stroke. A likely explanation for the found 
associations is the indirect influence of coping styles on CVD risk factors indicating that 
improved education on stress- management and coping styles may improve lifestyle habits, 
participation rates in screening programs and compliance with treatment.  
Positive reappraisal is inversely associated with overall cancer mortality. Although 
specific coping styles and their interactions are not associated with overall cancer incidence, 
they are associated with certain cancer subtypes, localized cancer at time of diagnosis, and 
with cancers detected through screening. The results of this study may speak in favour of the 
behavioural hypothesis to explain associations between premorbid coping styles and cancer 
outcomes. 
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Appendix A: Supplementary figures  
Supplementary Figure 1: Network graph representing correlations between the different 
coping styles for cardiovascular disease end points. Green nodes represent approach 
oriented styles and pink nodes avoidance oriented styles. 
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Supplementary Figure 2: Causal graph with possible interrelation between covariates and premorbid coping strategies and their correlation to 
cardiovascular events. Green arrows=positive association; red arrows=negative association; blue arrows=undetermined association 
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Appendix B: Supplementary tables 
 
 
Supplementary Table 1: Correlation matrix for coping styles for analyses on cancer end points 
 
Coping style Planning Consulting someone Positive reappraisal Fantasizing Avoidance Self-blame 
Planning 1      
Consulting someone 0.175 1     
Positive reappraisal 0.443 0.188 1    
Fantasizing 0.114 0.170 0.204 1   
Avoidance 0.051 0.070 0.116 0.147 1  
Self-blame 0.064 0.094 0.102 0.226 0.142 1 
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Appendix C: JPHC 10-year follow-up questionnaire (English version) 
 
 
 
 
 
 
 
 
Health Promotion Questionnaire 
 
   
   
   
 
If you made an error in your name or address, please correct it with a red pen. 
 
The Ministry of Health and Welfare: The Japan Public Health Center-based 
prospective Study on Cancer and Cardiovascular Disease Research Group 
 
Kept by Secretariat 
National Cancer Center 
National Cardiovascular Center 
 
 
 
 
 
 
 
 
 
 
 
We may call to ask you some 
questions regarding the contents of 
what you have filled in. Please 
provide your phone number below if 
you do not mind. 
Do not fill in 
2 
 
Before starting the questionnaire 
 
The Epidemiology Research Group of the Ministry of Health, Labor and Welfare is 
working on research on “How can we prevent lifestyle diseases such as cancer, stroke, 
myocardial infarction, etc.?”  In this context,we have carried out the “Health Promotion 
Questionnaire” twice, mainly in 1990 and 1995, targeting people who were born from 1930 
through 1949 who live in cities, towns and villages. 
Five years have passed since the survey in 1995, and we are carrying out this third 
questionnaire to find out whether there have been any changes in lifestyle or health status of 
people during this interval, and also about details of your diet.  We would like to ask your 
cooperation now that you understand the background of this survey.  For those of you who 
did not participate in the previous questionnaires, we certainly would like to ask your 
cooperation this time. 
If you are willing to participate this time, please read the “Instructions on How to Filli in the 
Questionnaire” below and answer the questions beginning on the following page. 
 
Instructions on How to Fill in the Questionnaire 
1. As much as possible, please fill in this questionnaire by yourself. 
2. Please fill in the given space (the oval circles) that apply with a black pencil, or enter a number or letter 
in the box..  If you choose “Other” in the multiple choice selections, please fill in specific details in the 
parentheses. 
3. Please use an HB, B or H graphite pencil. 
4. Please do not use a fountain pen or ballpoint pen. 
5. If you have any corrections, please erase them entirely with an eraser. 
6. Please do not fill in anything in the blank spaces. 
(example for filling in the mark) 
 
 
 
 
For example, please fill it in as shown below if you currently smoke cigarettes, and if you started smoking 
at age 20. 
 
 
   
Good 
Example 
Bad 
Example 
outside the oval too 
narrow 
too short 
Currently, do you smoke cigarettes? 
I smoke I quit I do not smoke 
At what age did you quit smoking cigarettes? 
From what age did you start smoking? 
years of age 
years of age 
years of age 
From what age did you start 
smoking? 
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Please mark the month when you answered this questionnaire. 
January February March April May June 
July August September October November
 December 
 
What is your gender? Male Female 
 
Have you been told by your healthcare provider that you have any of the following diseases, or have you 
had any of the following operations?  If there is a disease or operation that applies, please mark the 
general time frame for that. 
 
Disease 
Time Frame when First Diagnosed 
1989 or Before 1990 - 1994 1995 or After 
Cancer Stomach Cancer    
 Colon Cancer    
 Lung Cancer    
 Liver Cancer    
 Breast Cancer    
 Uterine Cancer    
 Other Cancer ( )    
Cardiovascular 
Disease 
Stroke (cerebral hemorrhaging, cerebral infarction, 
subarachnoid hemorrhage)    
Myocardial Infarction    
Angina Pectoris    
Other Diseases Diabetes    
 Cataracts    
 Stomach Ulcers    
 Stomach Polyps    
 Duodenal Ulcers    
 Colon Polyps    
 Chronic Hepatitis or Cirrhosis of the Liver    
 Gall Stones    
 Urethral Stones or Kidney Stones    
 Gout    
 Hip Fracture, except from traffic accident or work accident    
 
Arm or Wrist Fracture, except from traffic accident or 
work accident    
Diseases other than those written above ( )    
Endoscopic Surgery  
*Endoscopic surgery is to cut out mucous membranes or polyps, etc. 
with a stomach camera, stomach fiber or colon fiber, etc. 
Time Frame when First Having 
Endoscopic Surgery 
1989 or Before 1990 - 1994 1995 or After 
Site Stomach    
 Colon    
 Endoscopic Surgery on Other Site ( )    
 
Surgery 
*Not including endoscopic surgery 
Time Frame when First Having Surgery 
1989 or Before 1990 - 1994 1995 or After 
Site Stomach    
 Colon    
 Gallbladder (Gall Stones)    
 Breast    
 Uterus    
 Ovaries    
 Lung    
 Liver    
 Surgery on Other Site ( )    
  Do not fill in   
4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Currently, is there a medicine that is prescribed by your healthcare provider and that you take periodically? 
Yes No 
If “Yes,” please mark all that apply. 
To the Next 
Question 
Hypertension 
Medicine 
Diabetes Medicine 
Medicine to Lower Cholesterol 
Gout Medicine Other 
 Fill in the name of the medicine 
Mark Not 
Necessary 
Is there any dietary health supplement that you have been taking with the frequency of once or more 
a week continually for one year or more? 
Yes No 
Please fill in the 
product name or 
type, frequency, time 
period for each 
dietary health 
supplement modeled 
after the example. 
to the next 
page 
Dietary health supplements here mean those non-food things taken 
in the form of tablets or powders, liquids, etc. like those written below. 
< Examples of Dietary Health Supplements > 
Vitamin agents: 
Multivitamins (alinamin A, etc.), vitamin B (chocola BB, etc.), 
vitamin C (Hi-C, etc.), vitamin E (juvelux, etc.), etc. 
Mineral agents: 
Calcium, iron, etc. 
Drink agents: 
Lipovitan D, Fibe-Mini, etc. 
Extracts from Food Products: 
Agaricus, propolis, turmeric, liver oil, etc. 
(Example) If you have continually been taking “Hi-C S” once daily for 8 years, or 
“Lipovitan D” 1 - 2 times a week for 2 years, please fill it in as follows. 
W
h
e
th
e
r 
T
a
k
e
n
 o
r 
N
o
t 
Product Name or Type 
1
 -
 2
 t
im
e
s
 a
 w
e
e
k
 
3
 -
 4
 t
im
e
s
 a
 w
e
e
k
 
5
 -
 6
 t
im
e
s
 a
 w
e
e
k
 
O
n
c
e
 d
a
ily
 
2
 -
 3
 t
im
e
s
 d
a
ily
 
1
 -
 2
 y
e
a
rs
 
3
 -
 4
 y
e
a
rs
 
2
0
 y
e
a
rs
 o
r 
m
o
re
 
5
 -
 9
 y
e
a
rs
 
1
0
 -
 1
9
 y
e
a
rs
 
Frequency Time Period 
Product Name or Type 
W
h
e
th
e
r 
T
a
k
e
n
 
o
r 
N
o
t 
1
 -
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 t
im
e
s
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 w
e
e
k
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k
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k
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 d
a
ily
 
2
 -
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 t
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 d
a
ily
 
4
 t
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m
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 d
a
ily
 
1
 -
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 y
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a
rs
 
3
 -
 4
 y
e
a
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5
 -
 9
 y
e
a
rs
 
1
0
 -
 1
9
 y
e
a
rs
 
2
0
 y
e
a
rs
 o
r 
m
o
re
 
Frequency Time Period 
Lipovitan D 
Hi-C S 
4
 t
im
e
s
 o
r 
m
o
re
 
d
a
ily
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About how tall are you currently? About how much do you weigh currently? 
100 digit 10 digit 1 digit  
   
(round off the fractions) 
cm 
 
100 digit 10 digit 1 digit  
   
(round off the fractions) 
kg 
 
 
About how much did you weigh when you were 
around 20 years old? 
100 digit 10 digit 1 digit  
   
(round off the fractions) 
kg 
 
 
 
   
Do you currently smoke cigarettes? 
I smoke I quit I do not smoke 
How old were you when you quit? 
At what age did you start smoking? 
From what age did you start 
smoking? 
How many cigarettes did you smoke a day? 
How many cigarettes do you smoke 
a day? 
years of age 
cigarettes 
years of age years of age 
cigarettes 
Would you like to quit 
smoking?  
(Please mark one) 
Why is it that you stopped smoking? 
(Please mark one or more) 
 
Why is it that you do not smoke? 
(Please mark one or more) 
I would 
I would like to reduce 
the number I smoke 
I would not 
Because it damaged my health 
Because it was not good for my future health 
Because it bothered the people around me 
Because there are more restrictions on 
where I can smoke in public 
Because of economic reasons 
Other 
Because I have not been so healthy 
Because it does not fit my own character 
Because it is not good for my future health 
Because it bothers the people around me 
Because of economic reasons 
Other 
About how often did you have the opportunity to inhale second-hand smoke (one hour or more per day) at 
home, the work place, stores, etc? 
At the age of 
10 
At the age of 
30 
Currently 
hardly ever 
1 - 3 days per 
month 
1 - 4 days per 
week 
almost every 
day 
hardly ever 
1 - 3 days per 
month 
1 - 4 days per 
week 
almost every 
day 
hardly ever 
1 - 3 days per 
month 
1 - 4 days per 
week 
almost every 
day 
Do not fill in 
6 
 
Do you think you are tolerant of alcohol? 
Tolerant Normal Intolerant I do not know 
 
When you drink alcohol, does your face quickly become red? 
It does Somewhat It does not I do not know 
 
 
 
 
Currently, do you drink alcohol? 
I do I quit I do not 
At what age did you quit drinking alcohol? 
years of age 
Why do you drink? 
(Please mark one) 
Because I like it 
To socialize 
Why is it that you quit drinking 
alcohol? 
(Please mark one or more) 
Why do you not drink alcohol? 
(Please mark one or more) 
To the next page 
Because it damaged my health 
Because it did not fit my character 
Because it was not good for my future health 
Because the number of drinking 
opportunities decreased 
Because of economic reasons 
Other (                                 ) 
Because I have not been so healthy 
Because it does not fit my own character 
Because it is not good for my future health 
Because I do not have drinking 
opportunities 
Because of economic reasons 
Other (                                                       ) 
How frequently do you drink? (For a person who quit, please provide information of the time when you 
were drinking) 
I hardly ever drink 1 - 3 days a month 1 - 2 days a week 
3 - 4 days a week 5 - 6 days a week I drink every day 
 
Please choose the most usual combination that you drink in one day. 
 
 
 
 
Japanese Sake 1 go (180ml) 
Shochu or Awamori 1 go undiluted (180ml) 
 
Beer Large bottle (633ml) (Please make the conversion at medium bottle or 500ml can, 0.8 of a bottle; 
small bottle or 350ml can, 0.6 of a bottle) 
 
Whiskey Single (30ml) 
Wine  Glass (100ml) 
 
(Example) If normally after drinking one large bottle of beer you drink 2 go of Japanese 
sake, in the “Beer” area fill in “1 bottle” and in the “Japanese Sake” area fill in “2 go,” 
and in the “Shochu or Awamori,” “Whiskey,” and “Wine” areas, fill in “I do not drink.” 
I do not drink less than 0.5 go 1 go 2 go 3 go 4 go 5 - 6 go 7 go or more 
I do not drink less than 0.5 go 1 go 2 go 3 go 4 go 5 - 6 go 7 go or more 
I do not drink less than 0.5 bottle 1 bottle 2 bottles 3 bottles 4 bottles 5 - 6 bottles 7 bottles or more 
I do not drink less than 0.5 glass 1 glass 2 glasses 3 glasses 4 glasses 5 - 6 glasses 7 bottles or more 
I do not drink less than 0.5 glass 1 glass 2 glasses 3 glasses 4 glasses 5 - 6 glasses 7 bottles or more 
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Questions about Your Dietary Life 
 
Now some questions about your diet will follow. 
Recalling your diet over the past one year, please answer with average frequencies and 
amounts. 
If you answer all the items, a detailed nutritional calculation of your normal dietary life can 
be made, so we will be able to report to each of you individually at a later date whether you 
have a nutritional balance, or whether your vitamins are enough, etc. 
There are a lot of questions, and this may be difficult for you, but we ask you to please 
complete it to the end. 
 
We are going to ask you about “rice (cooked rice).” 
About what size rice bowl do you eat with? 
Small rice bowl Normal rice bowl (female) Normal rice bowl (for male) 
Donburi/large rice bowl 
About how many bowls do you eat in 1 day, combining breakfast, lunch and dinner? 
Less than 1 bowl 1 bowl 2 bowls 3 bowls 4 bowls 
5 bowls 6 bowls 7 - 9 bowls 10 bowls or more 
Do you eat vitamin-enriched rice? 
No I rarely eat it I sometimes eat it I often eat it I always eat it 
Do you mix in wheat? 
I do not mix it in I rarely mix it in I sometimes mix it in I often mix it in 
I always mix it in 
Do you mix in millet or Japanese hie? 
I do not mix it in I rarely mix it in I sometimes mix it in I often mix it in 
I always mix it in 
 
We are going to ask you about “miso soup.” 
How frequently do you eat it? 
I hardly ever eat it 1 - 3 days a month 1 - 2 days a week 3 - 4 days a week 
5 - 6 days a week I eat it every day 
 
About how many cups do you eat in 1 day, combining breakfast, lunch and dinner? 
Less than 1 cup 1 cup 2 cups 3 cups 4 cups 
5 cups 6 cups 7 - 9 cups 10 cups or more 
 
How do you season it? 
Fairly diluted Somewhat diluted Normal Somewhat thick Fairly thick 
 
 
 
 
 
Do not fill in 
8 
 
Recalling your diet over the past one year, please fill in average frequencies and 
amounts. 
 
Example of how to fill it in 
If you eat beef steak about 2 times a month, and the amount you eat per time is about half a slice, then fill it 
in as follows. 
 
 
 
 
 
 
 
 
 
 
 
If you hardly ever eat beef steak (less than once a month), fill it in as follows. 
 
 
 
 
 
 
 
 
 
 
 
Do not fill in anything in the estimated amount. 
 
 
Name of Food Item 
B
e
e
f Steak 
Grilled (grilled meat, etc.) 
Estimated Amount 
Per Time 
1 steak slice (about 150g) 
5 thin slices (about 100g) 
L
e
s
s
 t
h
a
n
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n
c
e
 a
 
m
o
n
th
 
Estimated Amount Per 
Time 
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h
a
lf
 o
r 
le
s
s
) 
th
a
n
 
th
e
 e
s
ti
m
a
te
d
 a
m
o
u
n
t 
S
a
m
e
 a
s
 t
h
e
 e
s
ti
m
a
te
d
 
a
m
o
u
n
t 
M
o
re
 (
1
.5
 t
im
e
 o
r 
m
o
re
) 
th
a
n
 t
h
e
 e
s
ti
m
a
te
d
 a
m
o
u
n
t 
Name of Food Item 
B
e
e
f Steak 
Grilled (grilled meat, etc.) 
Estimated Amount 
Per Time 
1 steak slice (about 150g) 
5 thin slices (about 100g) 
L
e
s
s
 t
h
a
n
 o
n
c
e
 a
 
m
o
n
th
 
Estimated Amount Per 
Time 
5
 -
 6
 t
im
e
s
 a
 w
e
e
k
 
O
n
c
e
 d
a
ily
 
2
 -
 3
 t
im
e
s
  
d
a
ill
y
 
4
 -
 6
 t
im
e
s
 d
a
ily
 
7
 t
im
e
s
 o
r 
m
o
re
 d
a
ily
 
1
 -
 3
 t
im
e
s
 a
 m
o
n
th
 
1
 -
 2
 t
im
e
s
 a
 w
e
e
k
 
3
 -
 4
 t
im
e
s
 a
 w
e
e
k
 
L
e
s
s
 (
h
a
lf
 o
r 
le
s
s
) 
th
a
n
 
th
e
 e
s
ti
m
a
te
d
 a
m
o
u
n
t 
S
a
m
e
 a
s
 t
h
e
 e
s
ti
m
a
te
d
 
a
m
o
u
n
t 
M
o
re
 (
1
.5
 t
im
e
 o
r 
m
o
re
) 
th
a
n
 t
h
e
 e
s
ti
m
a
te
d
 a
m
o
u
n
t 
Name of Food Item 
B
e
e
f Steak 
Grilled (grilled meat, etc.) 
Stir-Fried (vegetable stir-fry, etc.) 
Stewed (curry or stew, etc.) 
Estimated Amount 
Per Time 
1 steak slice (about 150g) 
5 thin slices (about 100g) 
3 thin slices (about 60g) 
3 pieces 2 - 3cm-diced (about 50g) 
L
e
s
s
 t
h
a
n
 o
n
c
e
 a
 m
o
n
th
 Estimated Amount Per 
Time 
5
 -
 6
 t
im
e
s
 a
 w
e
e
k
 
O
n
c
e
 d
a
ily
 
2
 -
 3
 t
im
e
s
 d
a
ily
 
4
 -
 6
 t
im
e
s
 d
a
ily
 
7
 t
im
e
s
 o
r 
m
o
re
 d
a
ily
 
1
 -
 3
 t
im
e
s
 a
 m
o
n
th
 
1
 -
 2
 t
im
e
s
 a
 w
e
e
k
 
3
 -
 4
 t
im
e
s
 a
 w
e
e
k
 
L
e
s
s
 (
h
a
lf
 o
r 
le
s
s
) 
th
a
n
 
th
e
 e
s
ti
m
a
te
d
 a
m
o
u
n
t 
S
a
m
e
 a
s
 t
h
e
 e
s
ti
m
a
te
d
 
a
m
o
u
n
t 
M
o
re
 (
1
.5
 t
im
e
 o
r 
m
o
re
) 
th
a
n
 t
h
e
 e
s
ti
m
a
te
d
 a
m
o
u
n
t 
Stir-Fried (vegetable stir-fry, etc.) 
Fried (port cutlet, etc.) 
Stewed (curry or stew, 
etc.) 
Boiled (boiled kakuni or 
Okinawan name: rafty, etc.) 
Soups (pork soup or Okinawan 
name: chumi soup, etc.) 
 
Pork liver (Nirareba stir-fry, etc.) 
3 thin slices (about 60g) 
1 pork cutlet (about 100g) 
3 pieces 2 - 3cm-diced (about 50g) 
 
2 slices (about 60g) 
 
2 thin slices (about 40g) 
 
2 slices (about 40g) 
P
o
rk
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Recalling your diet over the past one year, please fill in average frequencies and 
amounts. 
Name of Food Item 
L
e
s
s
 t
h
a
n
 o
n
c
e
 a
 
m
o
n
th
 
1
 -
 3
 t
im
e
s
 a
 m
o
n
th
 
1
 -
 2
 t
im
e
s
 a
 w
e
e
k
 
3
 -
 4
 t
im
e
s
 a
 w
e
e
k
 
5
 -
 6
 t
im
e
s
 a
 w
e
e
k
 
O
n
c
e
 e
v
e
ry
 d
a
y
 
2
 -
 3
 t
im
e
s
 e
v
e
ry
 d
a
y
 
4
 -
 6
 t
im
e
s
 e
v
e
ry
 d
a
y
 
Estimated Amount 
Per Time 
Estimated Amount 
Per Time 
L
e
s
s
 (
h
a
lf
 o
r 
le
s
s
) 
th
a
n
 
th
e
 e
s
ti
m
a
te
d
 a
m
o
u
n
t 
S
a
m
e
 a
s
 t
h
e
 
e
s
ti
m
a
te
d
 a
m
o
u
n
t 
M
o
re
 (
1
.5
 t
im
e
 o
r 
m
o
re
) 
th
a
n
 t
h
e
 e
s
ti
m
a
te
d
 
a
m
o
u
n
t 
C
h
ic
k
e
n
 
Grilled (yakitori, etc.)         
2 skewers of yakitori (about 
70g)    
Stir-Fried (vegetable stir-
fry, etc.)         
5 slices (about 60g)    
Boiled         2-3cm dices (about 50g)    
Fried (karaage, etc.)         3 pieces (about 50g)    
Chicken liver (yakitori, etc.)         
1 skewer of yakitori (about 
30g)    
Roast Ham         1 normal slice (about 15g)    
Wieners and Sausages         2 pieces (about 30g)    
Bacon         1 strip (about 20g)    
Canned Luncheon Meet         1/8 can (about 40g)    
M
ilk
 Low-fat milk         1 200cc-glass    
Normal milk         1 200cc-glass    
Eggs         1 medium (about 50g)    
Cheese         
1 slice of sliced cheese 
(about 20g)    
Yogurt         1 container (about 120g)    
Salted cod, salted mackerel, 
salted salmon         
1 slice of fish meat (about 
70g)    
Dried fish (open dried flavor)         1 piece (about 50g)    
Canned tuna (sea chicken flakes)         1/4 can (about 20g)    
Salmon or trout         
1 slice of fish meat (about 
70g)    
Bonito or tuna         4 raw slices (about 60g)    
Yellowtail or kingfish         4 raw slices (about 60g)    
Cod or flounder         1/2 slice (about 40g)    
Bream (Red Sea bream, Okinawan name: 
gurkun, Okinawan name:  machi, etc.)         1 slice (about 70g)    
Horse mackerel or sardines         1 fish (about 80g)    
Pike or mackerel         1 fish (about 80g)    
Dried whitebait         
2 tablespoonfuls (about 
10g)    
Cod roe or salmon roe         1/4 sac (about 20g)    
Eel         1/2 fish (about 50g)    
Squid         3 raw slices (about 50g)    
Octopus         1/3 tentacle (about 50g)    
Shrimp         
2 Taisho shrimp (about 
40g)    
Clams or freshwater clams         
10 shucked pieces of meat 
(about 20g)    
Snails         
10 shucked pieces of meat 
(about 20g)    
Fish cake         1/6 tube (about 20g)    
Fish paste         2 slices (about 20g)    
 Do not fill in 
10 
 
Estimated Amount of Vegetables (full size) 
 
If the amount you eat per time is about the same as in the photograph, please fill 
in “Same.”  If it is more than what is in the photograph (1.5 times or more), please 
fill in “More,” and if less (less than half), please fill in “Less.” 
 
 
 
 
 
 
 
 
 
 
(a) Carrot, 1/4 carrot 
(about 50g) 
(c) Pumpkin,  4 - 5cm cube 
(about 40g) 
(e) Radish,  2-cm-thick round slice 
(about 80g) 
(b) Spinach, 2 bunches 
(about 50g) 
(d) Cabbage, 1/2 medium-sized leaf 
(about 30g) 
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For the following vegetables, please refer to the photographs on the page on the 
left, and fill in the frequency or amount you eat in the season when they are 
available on the market. 
Name of Food Item 
L
e
s
s
 t
h
a
n
 o
n
c
e
 a
 
m
o
n
th
 
1
 -
 3
 t
im
e
s
 a
 m
o
n
th
 
1
 -
 2
 t
im
e
s
 a
 w
e
e
k
 
3
 -
 4
 t
im
e
s
 a
 w
e
e
k
 
5
 -
 6
 t
im
e
s
 a
 w
e
e
k
 
O
n
c
e
 d
a
ily
 
2
 -
 3
 t
im
e
s
 d
a
ily
 
4
 -
 6
 t
im
e
s
  
d
a
ily
 
Estimated Amount 
Per Time 
Estimated Amount 
Per Time 
L
e
s
s
 (
h
a
lf
 o
r 
le
s
s
) 
th
a
n
 
th
e
 e
s
ti
m
a
te
d
 a
m
o
u
n
t 
S
a
m
e
 a
s
 t
h
e
 
e
s
ti
m
a
te
d
 a
m
o
u
n
t 
M
o
re
 (
1
.5
 t
im
e
 o
r 
m
o
re
) 
th
a
n
 t
h
e
 e
s
ti
m
a
te
d
 
a
m
o
u
n
t 
Carrot         Refer to photograph (a)    
Spinach         Refer to photograph (b)    
Pumpkin         Refer to photograph (c)    
Cabbage         Refer to photograph (d)    
Radish         Refer to photograph (e)    
 
For the following vegetables and fruits, please fill in the frequency or amount 
you eat in the season when they are available on the market. 
 
T
s
u
k
e
m
o
n
o
 P
ic
k
le
s
 
Takuwan         3 slices (about 30g)    
Green-leafed tsukemono 
(Nozawana, leaf mustard)         
1 small tsukemono plate 
(about 30g)    
Dried plums         1 medium plum (about 8g)    
Chinese cabbage         
1 small tsukemono plate 
(about 30g)    
Cucumbers         
1 small tsukemono plate 
(about 30g)    
Eggplant         
1 small tsukemono plate 
(about 30g)    
Green peppers         1 pepper (about 30g)    
Tomatoes         ¼ tomato (about 50g)    
Green onions         ¼ stalk (about 20g)    
Leeks         2 leeks (about 20g)    
Edible chrysanthemums         1/3 bunch (about 30g)    
Rape         1 stalk (about 20g)    
Broccoli         3 stalks (about 30g)    
Onions         ¼ onion (about 50g)    
Cucumbers         1/3 cucumber (about 30g)    
Eggplant         1 eggplant (about 60g)    
Chinese cabbage         
1/3 medium leaf (about 
30g)    
Burdock root         ¼ root (about 40g)    
Bean sprouts         ¼ bag (about 25g)    
Haricot verts         6 beans (about 30g)    
Lettuces         1 medium leaf (about 10g)    
Chingensai 
(Okinawan name:  pak-choi)         
1 stalk (about 70g)    
Leaf mustard 
(Okinawan name: shimana)         
2 stalks (about 70g)    
 
 
Do not fill in 
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For the following vegetables and fruits, please fill in the frequency or amount 
you eat in the season when they are available on the market. 
Name of Food Item 
L
e
s
s
 t
h
a
n
 o
n
c
e
 a
 
m
o
n
th
 
1
 -
 3
 t
im
e
s
 a
 m
o
n
th
 
1
 -
 2
 t
im
e
s
 a
 w
e
e
k
 
3
 -
 4
 t
im
e
s
 a
 w
e
e
k
 
5
 -
 6
 t
im
e
s
 a
 w
e
e
k
 
O
n
c
e
 d
a
ily
 
2
 -
 3
 t
im
e
s
 d
a
ily
 
4
 -
 6
 t
im
e
s
 d
a
ily
 
Estimated Amount 
Per Time 
Estimated Amount 
Per Time 
L
e
s
s
 (
h
a
lf
 o
r 
le
s
s
) 
th
a
n
 
th
e
 e
s
ti
m
a
te
d
 a
m
o
u
n
t 
S
a
m
e
 a
s
 t
h
e
 
e
s
ti
m
a
te
d
 a
m
o
u
n
t 
M
o
re
 (
1
.5
 t
im
e
 o
r 
m
o
re
) 
th
a
n
 t
h
e
 e
s
ti
m
a
te
d
 
a
m
o
u
n
t 
Bitter melon 
(Okinawan name: goya)         
1/2 melon (about 100g)    
Swiss chard 
(Okinawan name: nsubana)         
2 stalks (about 100g)    
Sponge gourd 
(Okinawan name: nabera)         
1 gourd (about 100g)    
Mugwort 
(Okinawan name: fuchiba)         
1 head (about 10g)    
Papaya         1/4 papaya (about 50g)    
Mandarin oranges         2 oranges (about 140g)    
Other citrus types (Hasssaku, 
iyokan, oranges)         
1/2 of one (about 75g)    
Apples         1/2 apple (about 85g)    
Persimmons         1/2 persimmon (about 80g)    
Strawberries         5 berries (about 75g)    
Grapes         
10 large grapes (about 
100g)    
Melons         
1/4 prince melon (about 
60g)    
Watermelon         1/8 melon (about 1200g)    
Peaches         1/2 peach (about 65g)    
Nashi pears         1/2 pear (about 80g)    
Kiwi fruit         1/2 kiwi (about 50g)    
Pineapple         1/8 pineapple (about 130g)    
Banana         1 banana (about 75g)    
Mango         1/2 mango (about 75g)    
 
Recalling your diet over the past one year, please fill in average frequencies and 
amounts. 
Bread types 
(including pastries also)         
1 piece of 6 slices (about 
60g)    
Udon         
1 donburi bowlful (about 
250g)    
Soba         
1 donburi bowlful (about 
200g)    
Okinawa soba         
1 donburi bowlful (about 
200g)    
Ramen         
1 donburi bowlful (about 
220g)    
Mochi cakes         
1 commercially marketed 
cake (about 50g)    
Japanese confections 
(Daifuku, manju)         
1 confection (about 70g)    
Cakes         
1 slice small cake (about 
70g)    
Biscuits and Cookies         2 cookies (about 25g)    
Chocolate         
1/2 chocolate bar (about 
25g)    
Peanuts         20 peanuts (about 20g)    
 610085 13 
 
Recalling your diet over the past one year, please fill in average frequencies and 
amounts. 
Name of Food Item 
L
e
s
s
 t
h
a
n
 o
n
c
e
 a
 
m
o
n
th
 
1
 -
 3
 t
im
e
s
 a
 m
o
n
th
 
1
 -
 2
 t
im
e
s
 a
 w
e
e
k
 
3
 -
 4
 t
im
e
s
 a
 w
e
e
k
 
5
 -
 6
 t
im
e
s
 a
 w
e
e
k
 
O
n
c
e
 d
a
ily
 
2
 -
 3
 t
im
e
s
 d
a
ily
 
4
 -
 6
 t
im
e
s
 d
a
ily
 
Estimated Amount 
Per Time 
Estimated Amount 
Per Time 
L
e
s
s
 (
h
a
lf
 o
r 
le
s
s
) 
th
a
n
 
th
e
 e
s
ti
m
a
te
d
 a
m
o
u
n
t 
S
a
m
e
 a
s
 t
h
e
 
e
s
ti
m
a
te
d
 a
m
o
u
n
t 
M
o
re
 (
1
.5
 t
im
e
 o
r 
m
o
re
) 
th
a
n
 t
h
e
 e
s
ti
m
a
te
d
 
a
m
o
u
n
t 
Tofu (ingredient of miso soup)         5 cubes (about 20g)    
Tofu (fried tofu, or cold or cut into 
cubes)         
1/4 tofu cake (about 75g)    
Yushi dofu         
1 soup bowlful (about 
150g)    
Freeze-dried Takano tofu or shimi 
tofu         
1/2  slice (about 60g)    
Deep-fried tofu or thick-fried tofu         1/2  slice (about 60g)    
Fried auburaage tofu         
1 miso soup bowlful (about 
2g)    
Natto         1 small cup (about 50g)    
Satsuma sweet potatoes         1/6 potato (about 40g)    
Potatoes         1/3 potato (about 50g)    
Taro         1 taro (about 30g)    
Konnyaku pressed vegetables, 
shirataki konnyaku noodles         
about 2 oden pieces (about 
50g)    
Shiitake mushrooms         1 mushroom (about 20g)    
Enoki mushrooms         1/4 stalk (about 20g)    
Shimeji mushrooms         1/4 stalk (about 20g)    
Wakame seaweed or kelp         1 small bowlful (about 20g)    
Hijiki sea vegetable         1 small bowlful (about 20g)    
Nori dried seaweed (roasted 
seaweed or flavored seaweed)         
5 sheets of flavored nori 
(about 2g)    
 
Please answer with average frequencies and amounts of what you use at the 
dining table. 
Butter to put on bread         
amount to spread on 1 
piece of bread (about 8g)    
Margarine to put on bread         
amount to spread on 1 
piece of bread (about 8g)    
Jam or marmalade to put on bread         
amount to spread on 1 
piece of bread (about 8g)    
Dressing         1 tablespoonful (about 10g)    
Mayonnaise         
1/2 tablespoonful (about 
7g)    
Sauce         1 teaspoonful (5g)    
Ketchup         1 teaspoonful (6g)    
 
 
  
Do not fill in 
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How frequently do you drink the following beverages? 
 
Beverage Name 
L
e
s
s
 t
h
a
n
 o
n
c
e
 a
 
w
e
e
k
 
1
 -
 2
 t
im
e
s
 a
 w
e
e
k
 
3
 -
 4
 t
im
e
s
 a
 w
e
e
k
 
5
 -
 6
 t
im
e
s
 a
 w
e
e
k
 
A
 c
u
p
 o
r 
g
la
s
s
 
d
a
ily
 
2
 -
 3
 c
u
p
s
 o
r 
g
la
s
s
e
s
 d
a
ily
 
4
 -
 6
 c
u
p
s
 o
r 
g
la
s
s
e
s
 d
a
ily
 
7
 -
 9
 c
u
p
s
 o
r 
g
la
s
s
e
s
 d
a
ily
 
1
0
 c
u
p
s
 o
r 
g
la
s
s
e
s
 
o
r 
m
o
re
 d
a
ily
 
Soybean milk          
Japanese tea (green sencha tea)          
Japanese tea (coarse bancha tea or brown-
rice genmaicha tea)          
Oolong tea          
Black tea          
Coffee (other than canned coffee)          
Canned coffee          
Soup          
Lactic acid beverages (Yakult, etc.)          
100% fruit-juice orange juice          
100% fruit-juice apple juice          
Tomato juice          
Soft drinks (colas, etc.)          
Drink tonics (Lipovitan D, etc.)          
Drinking water (tap water or well water)          
Drinking water (marketed or water purifier)          
 
For people who drink black tea or coffee, do you add sugar or milk? 
 
I do not add 
them 
Half 
spoonful 
1 spoonful 2 spoonfuls 
3 or more 
spoonfuls 
Black tea 
Sugar      
Milk      
Coffee 
Sugar      
Milk      
 
 
How frequently do you eat breakfast? 
 
 
How frequently do you eat out? (Count bento boxed lunches and onigiri bought at stores as eating out) 
 
 
  
Less than 
once a 
month 
1 - 3 times 
a month 
1 - 2 times 
a week 
3 - 4 times 
a week 
5 - 6 times 
a week 
I eat it 
everyday 
Less than 
once a 
month 
1 - 3 times 
a month 
1 - 2 times 
a week 
3 - 4 times 
a week 
5 - 6 times 
a week 
I eat it 
everyday 
 610085 15 
 
How frequently do you eat instant foods? (ramen, cup noodles, packaged foods, etc.) 
 
 
How frequently do you eat stir-fried foods (stir-fried vegetables, etc.) cooked in oil? 
 
 
How frequently do you eat “deep-fat fried foods (fries, tempura, etc.)” cooked in oil? 
 
 
How much fat on the meat do you eat? 
 
 
How much soup of the ramen, udon or soba do you eat? 
 
 
Do you usually put salt on your food at the dining table? 
 
 
Do you usually put soy sauce on your food at the dining table? 
 
 
Please choose the oil you use most and mark only one. 
 
 
 
 
 
  
Less than 
once a 
month 
1 - 3 times 
a month 
1 - 2 times 
a week 
3 - 4 times 
a week 
5 - 6 times 
a week 
I eat it 
everyday 
Less than 
once a 
month 
1 - 3 times 
a month 
1 - 2 times 
a week 
3 - 4 times 
a week 
5 - 6 times 
a week 
I eat it 
everyday 
Less than 
once a 
month 
1 - 3 times 
a month 
1 - 2 times 
a week 
3 - 4 times 
a week 
5 - 6 times 
a week 
I eat it 
everyday 
I eat hardly 
any of it 
I eat about 1/3 
of it 
I eat about half 
of it 
I eat about 2/3 
of it 
I eat almost all 
of it 
I eat hardly 
any of it 
I eat about 1/3 
of it 
I eat about half 
of it 
I eat about 2/3 
of it 
I eat almost all 
of it 
I do not 
I rarely put it 
on 
I sometimes 
put it on 
I generally put it 
on 
I always put it 
on 
I do not 
I rarely put it 
on 
I sometimes 
put it on 
I generally put it 
on 
I always put it 
on 
Vegetable oil 
(prepared oil) 
Safflower oil 
(benibana oil) 
Corn oil 
Rapeseed oil 
or canola oil 
Soybean oil 
Olive oil Other 
Do not fill in 
16 
 
Please mark only one as the preparation method you use most often. 
 Raw Boiled Grilled 
Deep-Fat 
Fried 
Stir-Fried Other 
For meats?       
For fish?       
For vegetables?        
 
How do you most often eat steaks and grilled meats? 
 
 
How frequently do you eat grilled fish? 
 
 
When you eat grilled fish, do you eat the burned parts? 
 
 
Currently, whom do you live with?  Please mark all of the people that you live with. 
 
 
Has your work changed in the last 5 years? 
 
 
What is your current work?  If it changes because you work more than one job or seasonally, please 
mark all that apply. 
 
 
We are going to ask you about how you moved your body during the last one 
year. 
Compared to other one-year time periods such as a busy farming season, etc., has there been a 
particularly busy time period in which the way you moved your body during work time greatly changed?  
If there has been, please answer about that time period. 
 
  
Close to 
raw (rare) 
Somewhat 
close to raw 
Medium 
Somewhat well 
grilled 
Well grilled 
(well done) 
I hardly 
ever eat 
them 
I eat about 1/3 
of them 
I eat about half 
of them 
I eat about 2/3 
of them 
I eat almost all 
of them 
Spouse Child Parents Other I live alone 
I hardly 
ever eat it 
1 - 3 times 
a month 
1 - 2 times 
a week 
3 - 4 times 
a week 
5 - 6 times 
a week 
I eat it 
everyday 
It has not changed I changed jobs I retired and currently do not work 
Agricultural industry 
Specialty work 
Forestry industry 
Housewife 
Fishing industry 
Unemployed 
Office work 
Other 
Self-employed 
No such period 
3 months or more to less than 
4 months 
Less than 1 month 
4 months or more to less than 5 
months 
1 month or more to less than 2 
months 
5 months or more to less than 6 months 
2 months or more to less than 3 
months 
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How many hours do you work in a day?  Please answer including time for commuting and housework.  
For persons who had a particularly busy time period, please answer for that time period also. 
 
Less than 
1 hour 
1 hour or 
more and 
less than 3 
hours 
3 hours or 
more and 
less than 5 
hours 
5 hours or 
more and 
less than 7 
hours 
7 hours or 
more and 
less than 9 
hours 
9 hours or 
more and 
less than 
11 hours 
11 hours 
or more 
Normal time 
period        
Busy time 
period        
 
 
Please tell us about the breakdown of your work time for a normal 1 day period within the last 1 year.  
Please answer including time for commuting and housework. 
Breakdown of 
work time 
None 
Less 
than 1 
hour 
1 hour or 
more and 
less than 
3 hours 
3 hours or 
more and 
less than 5 
hours 
5 hours or 
more and 
less than 7 
hours 
7 hours or 
more and 
less than 
9 hours 
9 hours or 
more and 
less than 
11 hours 
11 
hours or 
more 
Sitting time during 
commute, work, 
housework, etc. 
        
Standing time 
during commute, 
work, housework, 
etc. 
        
Walking time during 
commute, work, 
housework, etc. 
        
Time when doing 
physical work  that 
need strength 
        
 
 
We are going to ask you about how you moved your body during your free time.  Last year, when you did 
the following things, how frequently did you do them and for how much time per occasion? 
How you moved your body 
during free time 
Frequency 
 
Time per occasion 
L
e
s
s
 t
h
a
n
 o
n
c
e
 
a
 m
o
n
th
 
1
 -
 3
 t
im
e
s
 
a
 m
o
n
th
 
1
 -
 2
 t
im
e
s
 
a
 w
e
e
k
 
3
 -
 4
 t
im
e
s
 
a
 w
e
e
k
 
A
lm
o
s
t 
e
v
e
ry
 d
a
y
 
L
e
s
s
 t
h
a
n
 
3
0
 m
in
u
te
s
 
3
0
 -
 5
9
 
m
in
u
te
s
 
1
 t
o
 l
e
s
s
 
th
a
n
 2
 h
o
u
rs
 
2
 t
o
 l
e
s
s
 
th
a
n
 3
 h
o
u
rs
 
3
 t
o
 l
e
s
s
 
th
a
n
 4
 h
o
u
rs
 
4
 h
o
u
rs
 o
r 
m
o
re
 
Walking leisurely on a stroll, etc.             
Walking briskly such as a power walk             
Light- or medium-degree exercise 
like golf, croquet, puttering around 
the garden, etc. 
            
Intense exercise like tennis, jogging, 
aerobics, swimming, etc.             
 
 
 
 
 
  
Do not fill in 
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During the last 1 year, how much sleep have you normally been getting? 
 
 
How frequently do you have a bowel movement? 
 
 
What kind of stool do you usually have? 
 
 
Are you regular in your everyday life? 
 
 
 
 
 
It is known that psychological and social factors are related to promoting health 
maintenance and the onset and passage of illnesses.  Below we will ask you 
about some matters thought to be related to health status.  Please do not over-
think them and mark respectively only one that applies to you. 
 
How do you handle various problems and events that you experience daily?  Please answer about those 
respective frequencies. 
How you handle them 
Hardly 
ever 
Infrequently Sometimes 
Fairly 
often 
Extremely 
often 
Make a plan to resolve them and carry 
it out      
Consult with someone      
Hope or fantasize about being able to 
change it      
Endeavor to find the positive side of the 
situation      
Blame and criticize yourself      
Avoid those things and do something 
else      
 
 
  
5 hours or 
less 
6 hours 7 hours 8 hours 9 hours 
10 hours 
or more 
Diarrhea Soft stool 
Normal 
stool 
Hard stool 
Particularly 
hard stool 
I repeatedly 
have diarrhea 
and constipation 
Less than 3 
times a 
week 
3 - 4 times a 
week 
5 - 6 times a 
week 
Once daily 
2 or more times 
daily 
I am regular I am not regular 
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Normally, how much do you lead your life suppressing feelings of anger and sadness and the actions 
that accompany them? 
 
Hardly 
ever 
Infrequently Sometimes 
Fairly 
often 
Extremely 
often 
Please answer about the frequency with 
which you suppress feelings and 
actions 
     
Please answer about how much you do 
this for these reasons 
(1) because it fits the situation and 
surrounding feelings, common 
sense and customs 
     
(2) because I do not understand my 
own feelings and expressing them 
is difficult 
     
How often does it become painful for 
you to suppress your feelings and 
actions? 
     
 
 
How frequently do you talk with people on a daily basis? 
 
 
Do you have the following kind of confidence about your life? 
 
I do not think 
this at all 
I think this a 
bit 
I generally 
think so 
I completely 
think so 
I think that my own life has good 
prospects to some degree.     
I think that in life whatever happens, it 
will work out.     
Life is worth living meaningfully.      
 
How long does it take for you to fall asleep after you get into bed? 
 
 
When you are asleep at night, do you ever fully wake up? 
 
 
Do you ever wake up early in the morning and cannot get back to sleep? 
 
   
Less than 
once a 
month 
1 - 3 times 
a month 
1 - 4 times 
a week 
Almost 
every day 
Everyday 
with several 
people 
Everyday with 
many people 
Less than 
10 minutes 
10 - 29 
minutes 
30 - 59 
minutes 
1 hour or more 
and less than 2 
hours 
2 hours or 
more 
Less than 
once a 
month 
1 - 3 times a 
month 
1 - 4 times a 
week 
Almost 
everyday 
Several times a 
day 
Less than once 
a month 
1 - 3 times a 
month 
1 - 4 times a 
week 
Almost everyday 
Do not fill in 
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If you have had any tests in the past one year, please mark all of them. 
 
 
If you have had your blood pressure or blood cholesterol measured in the past one year, please fill in the 
values at that time (if there were multiple times, the most recent values). 
Upper blood pressure number  Lower blood pressure number  Cholesterol number 
100 digit 10 digit 1 digit  100 digit 10 digit 1 digit  100 digit 10 digit 1 digit 
           
 
 
How is the current state of your daily life?  Please choose 1 from among the following 9 multiple choices 
that you think best applies and mark it. 
 
 
We are asking these only of women. 
Currently, do you take female hormone medications? 
Currently, do you have menses (menstruation)? 
 
 
For persons who have had menopause, at what age did you have menopause? 
 
 
Who filled this in? 
 
This is the end.  We would appreciate it if you would check once more that you 
have not omitted anything.  Thank you very much for your cooperation spending 
a long time on this. 
Blood pressure 
measurement 
Sputum cytological 
examination 
Intestinal 
endoscopy 
Blood test 
Stomach X-ray 
Breast X-ray 
Electro-
cardiogram 
Gastric 
endoscopy 
Uterine cytological examination 
Fundoscopy 
Occult 
blood test 
Chest X-ray 
Intestinal X-ray 
I do not particularly have any physical disability 
<You have some physical disability, but you can lead your daily life pretty much by yourself and get out on your own efforts> 
I go out using transportation facilities 
I go out only in the neighborhood 
<You can lead your life indoors generally by yourself, but do not get out without assistance> 
I get out with assistance, and during the day I mostly lead my life away from bed 
Getting out is infrequent, and even during the day I lead my life going to sleep and getting up 
<You need some kind of assistance to lead your life indoors, and even during the day you mainly lead your life in bed, but 
you can maintain a sitting position> 
I get into my wheelchair by myself, and I have my meals and toilet activities away from bed 
I get into my wheelchair with assistance 
<I spend the day in bed, and I need assistance in my toilet activities, meals, and changing clothes> 
I turn over in bed on my own strength 
I do not even turn over in bed on my own strength 
No Yes 
Yes I have had menopause 
naturally 
I have had menopause 
surgically, etc. 
Age 39 or under Age 40 - 44 Age 45 - 49 Age 50 - 54 Age 55 - 59 Age 60 or over 
Self Representative 
